Form 10-Q - Quarterly report [Sections 13 or 15(d)]

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

_______________________________________________________________________________________________________________________________________________________________________________________________________

FORM 10-Q


(Mark One)
☑	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
	For the quarterly period ended	September 30, 2024


☐						TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
						For the transition period from to

Commission File Number: 001-38214

HAMILTON BEACH BRANDS HOLDING COMPANY

(Exact name of registrant as specified in its charter)

Delaware

31-1236686

(State or other jurisdiction of incorporation or organization)

(I.R.S. Employer Identification No.)

4421 WATERFRONT DR.

GLEN ALLEN

23060

(Address of principal executive offices)

(Zip code)

(804)

273-9777

(Registrant’s telephone number, including area code)

N/A

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Class A Common Stock, Par Value $0.01 Per Share

HBB

New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No o

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes þ No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

☑

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No þ

Number of shares of Class A Common Stock outstanding as of October 25, 2024: 10,098,373

Number of shares of Class B Common Stock outstanding as of October 25, 2024: 3,606,543

HAMILTON BEACH BRANDS HOLDING COMPANY

TABLE OF CONTENTS

Page Number

Part I.

FINANCIAL INFORMATION

Item 1

Financial Statements

Consolidated Balance Sheets

Consolidated Statements of Operations

Consolidated Statements of Comprehensive Income (Loss)

Consolidated Statements of Cash Flows

Consolidated Statements of Changes in Equity

Notes to Unaudited Consolidated Financial Statements

Item 2

Management’s Discussion and Analysis of Financial Condition and Results of Operations

Item 3

Quantitative and Qualitative Disclosures About Market Risk

Item 4

Controls and Procedures

Part II.

OTHER INFORMATION

Item 1

Legal Proceedings

Item 1A

Risk Factors

Item 2

Unregistered Sales of Equity Securities and Use of Proceeds

Item 3

Defaults Upon Senior Securities

Item 4

Mine Safety Disclosures

Item 5

Other Information

Item 6

Exhibits

Signatures

Part I

FINANCIAL INFORMATION

Item 1. Financial Statements

HAMILTON BEACH BRANDS HOLDING COMPANY

CONSOLIDATED BALANCE SHEETS

(Unaudited)


	SEPTEMBER 30 2024		DECEMBER 31 2023		SEPTEMBER 30 2023
	(In thousands)
Assets
Current assets
Cash and cash equivalents	$	22,602	$	15,370	$	1,624
Trade receivables, net	99,049		135,434		102,178
Inventory	164,802		126,554		160,237

Prepaid expenses and other current assets	18,912		9,457		14,417

Total current assets	305,365		286,815		278,456
Property, plant and equipment, net	35,238		27,401		27,493
Right-of-use lease assets	36,627		39,423		40,590
Goodwill	7,099		6,253		6,253
Other intangible assets, net	2,179		1,292		1,342
Deferred income taxes	2,187		2,581		2,577
Deferred costs	15,434		14,613		14,419

Other non-current assets	4,540		6,324		7,790

Total assets	$	408,669	$	384,702	$	378,920
Liabilities and stockholders’ equity
Current liabilities
Accounts payable	$	128,489	$	99,704	$	116,124

Revolving credit agreements	50,000		—		—
Accrued compensation	12,622		14,948		11,025
Accrued product returns	6,616		6,232		5,801
Lease liabilities	5,584		6,155		6,136
Other current liabilities	10,130		12,549		12,776

Total current liabilities	213,441		139,588		151,862
Revolving credit agreements	—		50,000		51,276
Lease liabilities, non-current	39,528		41,937		43,303
Other long-term liabilities	5,749		5,910		4,659

Total liabilities	258,718		237,435		251,100
Stockholders’ equity
Preferred stock, par value $0.01 per share	—		—		—
Class A Common stock	115		112		112
Class B Common stock	36		36		36
Capital in excess of par value	77,779		70,401		68,180
Treasury stock	(21,878)		(12,013)		(10,409)
Retained earnings	101,430		99,398		81,362
Accumulated other comprehensive loss	(7,531)		(10,667)		(11,461)
Total stockholders’ equity	149,951		147,267		127,820
Total liabilities and stockholders’ equity	$	408,669	$	384,702	$	378,920

See notes to unaudited consolidated financial statements.

Table of Contents

HAMILTON BEACH BRANDS HOLDING COMPANY

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)


	THREE MONTHS ENDED SEPTEMBER 30				NINE MONTHS ENDED SEPTEMBER 30
	2024		2023		2024		2023
	(In thousands, except per share data)				(In thousands, except per share data)
Revenue	$	156,667	$	153,614	$	441,184	$	418,975
Cost of sales	112,765		113,548		326,732		330,583
Gross profit	43,902		40,066		114,452		88,392
Selling, general and administrative expenses	33,251		25,591		94,595		78,150
Amortization of intangible assets	31		50		224		150
Operating profit (loss)	10,620		14,425		19,633		10,092
Interest expense, net	59		592		330		2,634
Pension termination expense	7,595		—		7,595		—
Other expense (income), net	298		645		1,354		390
Income (loss) before income taxes	2,668		13,188		10,354		7,068
Income tax expense (benefit)	732		2,848		3,594		1,395


Net income (loss)	$	1,936	$	10,340	$	6,760	$	5,673




Basic and diluted earnings (loss) per share	$	0.14	$	0.74	$	0.48	$	0.40






Basic weighted average shares outstanding	13,852		14,025		14,042		14,060
Diluted weighted average shares outstanding	13,863		14,050		14,056		14,085

See notes to unaudited consolidated financial statements.

Table of Contents

HAMILTON BEACH BRANDS HOLDING COMPANY

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(Unaudited)


	THREE MONTHS ENDED SEPTEMBER 30				NINE MONTHS ENDED SEPTEMBER 30
	2024		2023		2024		2023
	(In thousands)				(In thousands)
Net income (loss)	$	1,936	$	10,340	$	6,760	$	5,673
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustment	(516)		(661)		(3,481)		(182)
(Loss) gain on long-term intra-entity foreign currency transactions	—		—		—		653
Cash flow hedging activity	(741)		249		851		(1,213)

Reclassification of hedging activities into earnings	(237)		473		(756)		1,002
Pension plan adjustment	695		—		695		—
Reclassification related to pension termination activity into earnings	5,658		—		5,658		—
Reclassification of pension adjustments into earnings	37		73		169		197
Total other comprehensive income (loss), net of tax	4,896		134		3,136		457
Comprehensive income (loss)	$	6,832	$	10,474	$	9,896	$	6,130

See notes to unaudited consolidated financial statements.

Table of Contents

HAMILTON BEACH BRANDS HOLDING COMPANY

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)


	NINE MONTHS ENDED SEPTEMBER 30
	2024		2023
	(In thousands)
Operating activities
Net income (loss)	$	6,760	$	5,673
Adjustments to reconcile net income (loss) to net cash provided by (used for) operating activities:
Depreciation and amortization	3,744		3,078

Stock compensation expense	7,381		3,175

Pension termination expense	7,595		—
Other	3,206		(172)
Net changes in operating assets and liabilities:

Trade receivables	34,599		13,678
Inventory	(43,687)		(3,379)
Other assets	(3,321)		2,333
Accounts payable	29,425		54,013
Other liabilities	(10,525)		(9,716)
Net cash provided by (used for) operating activities	35,177		68,683
Investing activities
Expenditures for property, plant and equipment	(2,347)		(2,286)
Acquisition of business, net of cash acquired	(7,412)		—

Issuance of secured loan	(600)		—
Repayment of secured loan	2,205		—
Purchase of U.S. Treasury bill	(4,884)		—
Other	—		(150)
Net cash provided by (used for) investing activities	(13,038)		(2,436)
Financing activities
Net additions (reductions) to revolving credit agreements	—		(59,650)
Purchase of treasury stock	(9,865)		(1,470)
Cash dividends paid	(4,728)		(4,549)



Net cash provided by (used for) financing activities	(14,593)		(65,669)





Effect of exchange rate changes on cash, cash equivalents and restricted cash	(390)		81
Cash, cash equivalents and restricted cash
Increase (decrease) for the period	7,156		659

Balance at the beginning of the period	16,379		1,905
Balance at the end of the period	$	23,535	$	2,564

Reconciliation of cash, cash equivalents and restricted cash

Cash and cash equivalents	$	22,602	$	1,624
Restricted cash included in prepaid expenses and other current assets	63		24
Restricted cash included in other non-current assets	870		916

Total cash, cash equivalents and restricted cash	$	23,535	$	2,564

See notes to unaudited consolidated financial statements.

Table of Contents

HAMILTON BEACH BRANDS HOLDING COMPANY

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY

(Unaudited)


	Class A Common Stock		Class B Common Stock		Capital in Excess of Par Value		Treasury Stock		Retained Earnings		Accumulated Other Comprehensive Income (Loss)		Total Stockholders’ Equity
	(In thousands, except per share data)
Balance, January 1, 2024	$	112	$	36	$	70,401	$	(12,013)	$	99,398	$	(10,667)	$	147,267
Net income (loss)	—		—		—		—		(1,162)		—		(1,162)
Purchase of treasury stock	—		—		—		(554)		—		—		(554)
Issuance of common stock, net of conversions	2		—		(2)		—		—		—		—
Share-based compensation expense	—		—		1,904		—		—		—		1,904
Cash dividends, $0.11 per share	—		—		—		—		(1,531)		—		(1,531)
Other comprehensive income (loss), net of tax	—		—		—		—		—		(1,060)		(1,060)
Reclassification adjustment to net income (loss)	—		—		—		—		—		543		543
Balance, March 31, 2024	114		36		72,303		(12,567)		96,705		(11,184)		145,407
Net income (loss)	—		—		—		—		5,986		—		5,986
Purchase of treasury stock	—		—		—		(3,985)		—		—		(3,985)

Share-based compensation expense	—		—		1,180		—		—		—		1,180
Cash dividends, $0.115 per share	—		—		—		—		(1,613)		—		(1,613)
Other comprehensive income (loss), net of tax	—		—		—		—		—		(313)		(313)
Reclassification adjustment to net income (loss)	—		—		—		—		—		(930)		(930)
Balance, June 30, 2024	114		36		73,483		(16,552)		101,078		(12,427)		145,732
Net income (loss)	—		—		—		—		1,936		—		1,936
Purchase of treasury stock	—		—		—		(5,326)		—		—		(5,326)
Issuance of common stock, net of conversions	1		—		(1)		—		—		—		—
Share-based compensation expense	—		—		4,297		—		—		—		4,297
Cash dividends, $0.115 per share	—		—		—		—		(1,584)		—		(1,584)
Other comprehensive income (loss), net of tax	—		—		—		—		—		(562)		(562)
Reclassification adjustment to net income	—		—		—		—		—		5,458		5,458
Balance, September 30, 2024	$	115	$	36	$	77,779	$	(21,878)	$	101,430	$	(7,531)	$	149,951

Table of Contents



Balance, January 1, 2023	$	107	$	38	$	65,008	$	(8,939)	$	80,238	$	(11,918)	$	124,534
Net income (loss)	—		—		—		—		(4,777)		—		(4,777)
Issuance of common stock, net of conversions	4		(2)		(2)		—		—		—		—

Share-based compensation expense	—		—		797		—		—		—		797
Cash dividends, $0.105 per share	—		—		—		—		(1,460)		—		(1,460)
Other comprehensive income (loss), net of tax	—		—		—		—		—		(916)		(916)
Reclassification adjustment to net income (loss)	—		—		—		—		—		251		251
Balance, March 31, 2023	111		36		65,803		(8,939)		74,001		(12,583)		118,429
Net income (loss)	—		—		—		—		110		—		110

Purchase of treasury stock	—		—		—		(575)		—		—		(575)
Share-based compensation expense	—		—		962		—		—		—		962
Cash dividends, $0.11 per share	—		—		—		—		(1,548)		—		(1,548)
Other comprehensive income (loss), net of tax	—		—		—		—		—		586		586
Reclassification adjustment to net income (loss)	—		—		—		—		—		402		402
Balance, June 30, 2023	111		36		66,765		(9,514)		72,563		(11,595)		118,366
Net income (loss)	—		—		—		—		10,340		—		10,340
Issuance of common stock, net of conversions	1		—		(1)		—		—		—		—
Purchase of treasury stock	—		—		—		(895)		—		—		(895)
Share-based compensation expense	—		—		1,416		—		—		—		1,416
Cash dividends, $0.11 per share	—		—		—		—		(1,541)		—		(1,541)
Other comprehensive income (loss), net of tax	—		—		—		—		—		(412)		(412)
Reclassification adjustment to net loss	—		—		—		—		—		546		546
Balance, September 30, 2023	$	112	$	36	$	68,180	$	(10,409)	$	81,362	$	(11,461)	$	127,820

See notes to unaudited consolidated financial statements.

Table of Contents

HAMILTON BEACH BRANDS HOLDING COMPANY

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2024

(Tabular amounts in thousands, except as noted and per share amounts)

NOTE 1—Basis of Presentation and Recently Issued Accounting Standards

Basis of Presentation

Throughout this Quarterly Report on Form 10-Q and the notes to unaudited consolidated financial statements, references to “Hamilton Beach Holding”, “the Company”, “we”, “us” and “our” and similar references are to Hamilton Beach Brands Holding Company and its subsidiaries on a consolidated basis unless otherwise noted or as the context otherwise requires. Hamilton Beach Brands Holding Company is a holding company and operates through its indirect, wholly owned subsidiary, Hamilton Beach Brands, Inc., a Delaware corporation (“HBB”). HBB is the Company’s single reportable segment.

We are a leading designer, marketer and distributor of a wide range of branded small electric household and specialty housewares appliances, as well as commercial products for restaurants, fast food chains, bars and hotels, and are a provider of connected devices and software for healthcare management.

The financial statements have been prepared in accordance with U.S. generally accepted accounting principles (GAAP) for interim financial information. Accordingly, they do not include all of the information and notes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments of a normal recurring nature considered necessary for a fair presentation have been included. These financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023.

Operating results for the nine months ended September 30, 2024 are not necessarily indicative of the results that may be expected for the remainder of the year due to the highly seasonal nature of the Company’s primary markets. A majority of revenue and operating profit typically occurs in the second half of the calendar year when sales of products to retailers and consumers historically increase significantly for the fall holiday-selling season.

We maintain a $150.0 million senior secured floating-rate revolving credit facility (the “HBB Facility”) that expires on June 30, 2025, within one year after the issuance of these financial statements. We have not yet completed our refinancing of the HBB Facility and, accordingly, all amounts outstanding have been classified as current liabilities. Based on the status of the refinancing and our history of successfully refinancing our debt, we believe that it is probable that the HBB Facility will be refinanced before its maturity. We believe funds available from cash on hand, the HBB Facility and operating cash flows will provide sufficient liquidity to meet our operating needs and commitments arising during the next twelve months.

Accounting Standards Not Yet Adopted

In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures,” which updates reportable segment disclosure requirements on an annual and interim basis. The amendments are effective for the annual period ending December 31, 2024, and the interim periods thereafter. Early adoption is permitted. Updates should be applied retrospectively to all prior periods presented in the financial statements. Adoption of this ASU may result in additional disclosure, but it will not impact the Company’s consolidated financial position, results of operations or cash flows.

In December 2023, the FASB issued ASU 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures,” which enhances income tax disclosure requirements primarily involving more detailed disclosure for income taxes paid and the effective tax rate reconciliation. The amendments are effective for annual periods beginning after December 15, 2024. Early adoption is permitted. The amendments should be applied prospectively but retrospective application is permitted. Adoption of this ASU may result in additional disclosure, but it will not impact the Company’s consolidated financial position, results of operations or cash flows.

Table of Contents

U.S. Pension Plan Termination

During 2022, the Board approved the termination of our U.S. defined benefit pension plan (the “U.S. Pension Plan”) with an effective date of September 30, 2022. During the third quarter of 2024, the Company remeasured the U.S. Pension Plan since benefit obligations were settled through a combination of lump sum payments to eligible plan participants and the purchase of a group annuity contract in August 2024, under which future benefit obligations were transferred to a third-party insurance company. The remaining benefit obligations through October 2024 will be settled during the fourth quarter of 2024. The remaining balance as of September 30, 2024 is a deferred loss of $0.1 million within Accumulated Other Comprehensive Income. The Company currently expects that all surplus assets remaining after the U.S. Pension Plan termination will be transferred to a qualified replacement plan once all remaining benefit obligations are settled. The surplus assets as of the remeasurement date of August 31, 2024 were $13.3 million which are included within prepaid expenses and other current assets on the Consolidated Balance Sheets. The remeasurement resulted in pre-tax settlement charges of $7.6 million ($5.7 million post-tax) during the three months ended September 30, 2024, which were released from Accumulated Other Comprehensive Income into earnings and are included within Pension termination expense on the Consolidated Statements of Operations.

Accounts payable - Supplier Finance Program

The Company has an agreement with a third-party administrator to provide an accounts payable tracking system which facilitates a participating supplier’s ability to monitor and voluntarily elect to sell payment obligations owed by the Company to the designated third-party financial institution. Participating suppliers can sell one or more of the Company’s payment obligations at their sole discretion. The Company has no economic interest in a supplier’s decision to sell one or more of its payment obligations. The Company’s rights and obligations with respect to such payment obligations, including amounts due and scheduled payment terms, are not impacted by suppliers’ decisions to sell amounts under these arrangements. The agreement has a limit of $60.0 million in payment obligations ($85.0 million during peak season from August to January). There is no requirement to provide assets pledged as security or other forms of guarantees under the agreement. The Company pays the third-party administrator based upon the original payment terms negotiated with participating suppliers. The payment of these obligations by the Company is included in cash used in operating activities in the Consolidated Statement of Cash Flows. As of September 30, 2024, December 31, 2023 and September 30, 2023, the Company has $70.1 million, $55.0 million and $72.8 million, respectively, in outstanding payment obligations that are presented in Accounts payable on the Consolidated Balance Sheets. Of these totals, the third-party financial institution has made payments to participating suppliers to settle $60.8 million, $48.9 million and $63.8 million, respectively, of our outstanding payment obligations.

U.S. Treasury Bills

During the third quarter of 2024, the Company invested $9.8 million of excess cash on hand into two U.S. Treasury Bills with original maturities of three and six months. U.S. Treasury Bills with an original maturity of 3 months or less are included within cash and cash equivalents on the Consolidated Balance Sheets and those greater than 3 months but less than one year are included within prepaid expenses and other current assets on the Consolidated Balance Sheets. The Company has classified these U.S. Treasury Bills as held-to-maturity as it intends to hold these securities until maturity. Held-to-maturity debt securities are recorded at amortized cost. Discounts from and premiums to par value on held-to-maturity debt securities are accreted/amortized into interest income over the life of the respective security using the effective interest method. The Company evaluates for other than temporary impairment on an ongoing basis. No impairment has been recognized for investments in debt securities for any period presented. As of September 30, 2024, the amortized cost and net carrying value of the securities recognized in cash and cash equivalents and prepaid expenses and other current assets were $5.0 million and $4.9 million, respectively.

NOTE 2—Transfer of Financial Assets

The Company has entered into an arrangement with a financial institution to sell certain U.S. trade receivables on a non-recourse basis. Under the terms of the agreement, the Company receives cash proceeds and retains no rights or interest and has no obligations with respect to the sold receivables. These transactions, which are accounted for as sold receivables, result in a reduction in trade receivables because the agreement transfers effective control over and risk related to the receivables to the buyer. Under this arrangement, the Company derecognized $33.5 million and $104.1 million of trade receivables during the three and nine months ending September 30, 2024, respectively, $30.7 million and $90.0 million of trade receivables during the three and nine months ending September 30, 2023, respectively, and $128.7 million during the year ending December 31, 2023. The loss incurred on sold receivables in the consolidated results of operations for the three and nine months ended September 30, 2024 and 2023 was not material. The Company does not carry any servicing assets or liabilities. Cash proceeds from this arrangement are reflected as operating activities in the Consolidated Statements of Cash Flows.

Table of Contents

NOTE 3—Fair Value Disclosure

The following table presents the Company’s assets and liabilities accounted for at fair value on a recurring basis:


Description	Balance Sheet Location	SEPTEMBER 30 2024		DECEMBER 31 2023		SEPTEMBER 30 2023
Assets:
Interest rate swap agreements
Current	Prepaid expenses and other current assets	$	798	$	511	$	929
Long-term	Other non-current assets	2,141		3,501		4,977
Foreign currency exchange contracts
Current	Prepaid expenses and other current assets	614		—		87
		$	3,553	$	4,012	$	5,993
Liabilities:



Foreign currency exchange contracts
Current	Other current liabilities	77		538		331
		$	77	$	538	$	331

The Company measures its derivatives at fair value using significant observable inputs, which is Level 2 as defined in the fair value hierarchy. The Company uses a present value technique that incorporates the Secured Overnight Financing Rate (SOFR) swap curve, foreign currency spot rates and foreign currency forward rates to value its derivatives, including its interest rate swap agreements and foreign currency exchange contracts. The Company also incorporates the effect of HBB and counterparty credit risk into the valuation.

Other Fair Value Measurement Disclosures

The carrying amounts of cash and cash equivalents, trade receivables and accounts payable approximate fair value due to the short-term maturities of these instruments, with the exception of U.S. Treasury bills classified as cash and cash equivalents which are measured at amortized cost.

The $150.0 million fair value of the HBB Facility, including book overdrafts, which approximate book value, was determined using current rates offered for similar obligations taking into account the Company’s credit risk, which is Level 2 as defined in the fair value hierarchy.

There were no transfers into or out of Levels 1, 2 or 3 during the three and nine months ended September 30, 2024.

Table of Contents

NOTE 4—Stockholders’ Equity

Capital Stock

The following table sets forth the Company’s authorized capital stock information:


	SEPTEMBER 30 2024	DECEMBER 31 2023	SEPTEMBER 30 2023

Preferred stock, par value $0.01 per share
Preferred stock authorized	5,000	5,000	5,000
Preferred stock outstanding	—	—	—
Class A Common stock, par value $0.01 per share
Class A Common authorized	70,000	70,000	70,000
Class A Common issued (1)(2)	11,459	11,161	11,126
Treasury Stock (3)	1,349	877	766
Class B Common stock, par value $0.01 per share, convertible into Class A Common stock on a one-for-one basis
Class B Common authorized	30,000	30,000	30,000
Class B Common issued (1)	3,608	3,616	3,625

(1) Class B Common converted to Class A Common were 3 and 8 shares during the three and nine months ending September 30, 2024, respectively, and 4 and 219 during the three and nine months ending September 30, 2023, respectively.

(2) The Company issued Class A Common of 14 and 290 shares during the three and nine months ending September 30, 2024, respectively, and 28 and 244 during the three and nine months ending September 30, 2023, respectively.

(3) On March 5, 2024, a total of 30 mandatory cashless-exercise-award shares of Class A Common were surrendered to the Company by the participants of our Executive Long-Term Equity Incentive Compensation Plan (the “Incentive Plan”) in order to satisfy the participants’ tax withholding obligations with respect to shares of Class A Common awarded under the Incentive Plan on March 5, 2024.

Stock Repurchase Program: In November 2023, the Company’s Board approved a stock repurchase program for the purchase of up to $25 million of the Company’s Class A Common outstanding starting January 1, 2024 and ending December 31, 2025. This program replaced the previous stock repurchase plan that started February 22, 2022 and ended December 31, 2023. During the three and nine months ended September 30, 2024, the Company repurchased 221,529 and 441,741 shares, respectively, at prevailing market prices for an aggregate purchase price of $5.3 million and $9.3 million, respectively. During the three and nine months ended September 30, 2023, the Company repurchased 82,676 and 139,649 shares, respectively, at prevailing market prices for an aggregate purchase price of $0.9 million and $1.5 million, respectively. During the year ended December 31, 2023, the Company repurchased 250,772 shares for an aggregate purchase price of $3.1 million. As of September 30, 2024, the Company had $15.7 million remaining authorized for repurchase.

Table of Contents

Accumulated Other Comprehensive Loss: The following table summarizes changes in accumulated other comprehensive loss by component and related tax effects for periods shown:


	Foreign Currency		Deferred Gain (Loss) on Cash Flow Hedging		Pension Plan Adjustment		Total

Balance, January 1, 2024	$	(6,412)	$	2,424	$	(6,679)	$	(10,667)
Other comprehensive income (loss)	(1,097)		29		—		(1,068)
Reclassification adjustment to net income (loss)	—		647		94		741
Tax effects	—		(167)		(23)		(190)
Balance, March 31, 2024	(7,509)		2,933		(6,608)		(11,184)
Other comprehensive income (loss)	(1,868)		2,104		—		236
Reclassification adjustment to net income (loss)	—		(1,325)		83		(1,242)
Tax effects	—		(215)		(22)		(237)
Balance, June 30, 2024	(9,377)		3,497		(6,547)		(12,427)
Other comprehensive income (loss)	(516)		(944)		932		(528)
Reclassification adjustment to net income (loss)	—		(310)		7,649		7,339
Tax effects	—		276		(2,191)		(1,915)
Balance, September 30, 2024	$	(9,893)	$	2,519	$	(157)	$	(7,531)

Balance, January 1, 2023	$	(8,924)	$	4,158	$	(7,152)	$	(11,918)
Other comprehensive income (loss)	715		(1,881)		—		(1,166)
Reclassification adjustment to net income (loss)	—		252		87		339
Tax effects	(194)		379		(23)		162
Balance, March 31, 2023	(8,403)		2,908		(7,088)		(12,583)
Other comprehensive income (loss)	425		(59)		—		366
Reclassification adjustment to net income (loss)	—		465		83		548
Tax effects	186		(89)		(23)		74
Balance, June 30, 2023	(7,792)		3,225		(7,028)		(11,595)
Other comprehensive income (loss)	(661)		329		—		(332)
Reclassification adjustment to net income (loss)	—		648		95		743
Tax effects	—		(255)		(22)		(277)
Balance, September 30, 2023	$	(8,453)	$	3,947	$	(6,955)	$	(11,461)

NOTE 5—Revenue

Revenue is recognized when control of the promised goods or services is transferred to the Company’s customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services, which includes an estimate for variable consideration.

The Company’s warranty program to the consumer consists generally of an assurance-type limited warranty lasting for varying periods of up to ten years for electric appliances, with the majority of products having a warranty of one to three years. There is no guarantee to the consumer as the Company may repair or replace, in its discretion, products returned under warranty. Accordingly, the Company determined that no separate performance obligation exists.

Most of the Company’s products are not sold with a general right of return. Subject to certain terms and conditions, however, the Company will agree to accept a portion of products sold that, based on historical experience, are estimated to be returned for reasons such as product failure and excess inventory stocked by the customer. Product returns, customer programs and incentive offerings, including special pricing agreements, price competition, promotions and other volume-based incentives are accounted for as variable consideration.

Table of Contents

A description of revenue sources and performance obligations for the Company are as follows:

Consumer and Commercial product revenue

Transactions with both consumer and commercial customers generally originate upon the receipt of a purchase order from a customer, which in some cases are governed by master sales agreements, specifying product(s) that the customer desires. Contracts for product revenue have an original duration of one year or less, and payment terms are generally standard and based on customer creditworthiness. Revenue from product sales is recognized at the point in time when control transfers to the customer, which is either when a product is shipped from a Company facility, or delivered to customers, depending on the shipping terms. The amount of revenue recognized varies primarily with price concessions and changes in returns. The Company offers price concessions to its customers for incentive offerings, special pricing agreements, price competition, promotions or other volume-based arrangements. The Company evaluated such agreements with its customers and determined returns and price concessions should be accounted for as variable consideration.

Consumer product revenue consists of sales of small electric household and specialty housewares appliances to traditional brick and mortar and ecommerce retailers, distributors and directly to the end consumer. A majority of this revenue is in North America.

Commercial product revenue consists of sales of products for restaurants, fast-food chains, bars and hotels. Approximately two-thirds of the Company’s commercial sales is in the U.S. and the remaining is in markets across the globe.

License revenue

From time to time, the Company enters into exclusive and non-exclusive licensing agreements which grant the right to use certain of the Company’s intellectual property (“IP”) in connection with designing, manufacturing, distributing, advertising, promoting and selling the licensees’ products during the term of the agreement. The IP that is licensed generally consists of trademarks, trade names, patents, trade dress, logos and/or products (the “Licensed IP”). In exchange for granting the right to use the Licensed IP, the Company receives a royalty payment, which is a function of (1) the total net sales of products that use the Licensed IP and (2) the royalty percentage that is stated in the licensing agreement. The Company recognizes revenue at the later of when the subsequent sales occur or when the performance obligation is satisfied over time. Additionally, the Company enters into agreements which grant the right to use software for healthcare management. The Company receives a license payment which is recognized when the performance obligation is satisfied over time or as usage occurs based on the contract with the customer.

Lease revenue

The Company leases connected devices to specialty pharmacy networks and pharmaceutical companies and is accounted for under Accounting Standards Codification 842, Leases as operating leases.

The following table sets forth Company’s revenue on a disaggregated basis for the three and nine months ended September 30:


	THREE MONTHS ENDED SEPTEMBER 30				NINE MONTHS ENDED SEPTEMBER 30
	2024		2023		2024		2023
Type of good or service:
Consumer products	$	141,862	$	138,849	$	394,397	$	374,842
Commercial products	12,041		13,159		39,914		40,234
Licensing	1,841		1,606		4,801		3,899
Leasing	923		—		2,072		—
Total revenues	$	156,667	$	153,614	$	441,184	$	418,975

Table of Contents

NOTE 6—Contingencies

The Company is involved in various legal and regulatory proceedings and claims that have arisen in the ordinary course of business, including product liability, patent infringement, asbestos related claims, environmental and other claims. Although it is difficult to predict the ultimate outcome of these proceedings and claims, the Company believes the ultimate disposition of these matters will not have a material adverse effect on the financial condition, results of operation or cash flows of the Company. Any costs that the Company estimates will be paid as a result of these claims are accrued when the liability is considered probable and the amount of such costs can be reasonably estimated. If a range of amounts can be reasonably estimated and no amount within the range is a better estimate than any other amount, then the minimum of the range is accrued. The Company does not accrue liabilities when the likelihood that the liability has been incurred is probable but the amount cannot be reasonably estimated or when the liability is believed to be only reasonably possible or remote. For contingencies where an unfavorable outcome is probable or reasonably possible and which are material, the Company discloses the nature of the contingency and, in some circumstances, an estimate of the possible loss.

Proceedings and claims asserted against the Company are subject to inherent uncertainties and unfavorable rulings could occur. If an unfavorable ruling were to occur, there exists the possibility of an adverse impact on the Company’s financial position and on the results of operations and cash flows for the period in which the ruling occurs, or in future periods.

Environmental matters

The Company is investigating or remediating historical environmental contamination at some current and former sites operated by the Company or by businesses it acquired. Based on the current stage of the investigation or remediation at each known site, the Company estimates the total investigation and remediation costs and the period of assessment and remediation activity required for each site. The estimate of future investigation and remediation costs is primarily based on variables associated with site clean-up, including, but not limited to, physical characteristics of the site, the nature and extent of the contamination and applicable regulatory programs and remediation standards.

No assessment can fully characterize all subsurface conditions at a site. There is no assurance that additional assessment and remediation efforts will not result in adjustments to estimated remediation costs or the time frame for remediation at these sites.

The Company’s estimates of investigation and remediation costs may change if it discovers contamination at additional sites or additional contamination at known sites, if the effectiveness of its current remediation efforts change, if applicable federal or state regulations change or if the Company’s estimate of the time required to remediate the sites changes. The Company’s current estimates may differ materially from original estimates.

As of September 30, 2024, December 31, 2023 and September 30, 2023, the Company had accrued undiscounted obligations of $3.5 million, $3.4 million and $3.4 million, respectively, for environmental investigation and remediation activities. The Company estimates that it is reasonably possible that it may incur additional expenses in the range of zero to $1.7 million related to the environmental investigation and remediation at these sites. As of September 30, 2024, the Company has $0.9 million, classified as restricted cash, associated with reimbursement of environmental investigation and remediation costs from a responsible party in exchange for release from all future obligations for one site. Additionally, the Company has a $1.6 million asset associated with the reimbursement of costs associated with two sites.

NOTE 7—Income Taxes

The Company’s provision for income taxes for interim periods is determined using an estimate of its annual effective tax rate, adjusted for discrete items, if any, that arise during the period. Each quarter, the Company updates its estimate of the annual effective tax rate, and if the estimated annual effective tax rate changes, the Company makes a cumulative adjustment in such period.

The effective tax rate was 27.4% and 21.6% for the three months ended September 30, 2024 and 2023, respectively. The effective tax rate was higher in the three months ended September 30, 2024 due to a valuation allowance on foreign losses in the current year and a tax benefit on foreign income in the prior year that did not recur.

The effective tax rate was 34.7% and 19.7% for the nine months ended September 30, 2024 and 2023, respectively. The effective tax rate was higher for the nine months ended September 30, 2024 due to a valuation allowance on foreign losses in the current year and tax benefits on foreign income and credits in the prior year that did not recur.

Table of Contents

NOTE 8—Acquisitions

On February 2, 2024, we completed the acquisition of HealthBeacon PLC (“HealthBeacon”), a medical technology firm and strategic partner of the Company, for €6.9 million (approximately $7.5 million). The transaction was funded with cash on hand.

The acquisition of HealthBeacon was accounted for as a business combination using the acquisition method of accounting. The results of operations for HealthBeacon are included in the accompanying Consolidated Statements of Operations from the acquisition date until September 30, 2024. HealthBeacon had $1.2 million and $2.6 million in revenue and $1.1 million and $3.7 million in operating loss that was included in our consolidated financial statements for the three and nine months ended September 30, 2024, respectively. Pro forma financial information has not been presented, as revenue and expenses related to the acquisition do not have a material impact on the Company’s unaudited consolidated financial statements.

The determination and allocation of purchase price consideration is based on preliminary estimates of fair value; such estimates and assumptions are subject to change within the measurement period (up to one year from the acquisition date). As of September 30, 2024, the purchase price allocation for HealthBeacon is preliminary as we assess and gather additional information regarding the fair value of the assets acquired and liabilities assumed as of the acquisition date. We may revise our preliminary estimates during the measurement period as third-party valuations are finalized, additional information becomes available and as additional analyses are performed.

There were no adjustments as allowed within the measurement period during the three months ended September 30, 2024.

During the three and nine months ended September 30, 2024, we incurred transaction costs of approximately $0.2 million and $1.3 million, respectively, which are included in Selling, general and administrative expenses.

The following table presents the preliminary value of assets acquired and liabilities assumed and will be finalized pending completion of purchase accounting matters:


	Preliminary Fair Values as of February 2, 2024
Cash and cash equivalents	$	147


Current assets	1,452
Property, plant and equipment, net	6,634

Goodwill	847
Other intangible assets, net	1,111

Total assets acquired	10,191
Liabilities, current	2,016
Liabilities, non-current	616
Total liabilities acquired	2,632
Purchase Price	$	7,559

Item 2. - Management’s Discussion and Analysis of Financial Condition and Results of Operations

(Dollars in thousands, except as noted and per share data)

Management’s Discussion and Analysis of Financial Condition and Results of Operations contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based upon management’s current expectations and are subject to various uncertainties and changes in circumstances. Important factors that could cause actual results to differ materially from those described in these forward-looking statements are set forth below under the heading “Forward-Looking Statements.”

HBB is the Company’s single reportable segment.

Table of Contents

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

For a summary of the Company’s critical accounting policies, refer to “Part II - Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations - Critical Accounting Policies and Estimates” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, as there have been no material changes from those disclosed in the Annual Report.

RESULTS OF OPERATIONS

The Company’s business is seasonal, and a majority of revenue and operating profit typically occurs in the second half of the year when sales of small electric appliances and kitchenware historically increase significantly for the fall holiday-selling season.

Third Quarter of 2024 Compared with Third Quarter of 2023


	THREE MONTHS ENDED SEPTEMBER 30
									Increase / (Decrease)
	2024		% of Revenue		2023		% of Revenue		$ Change		% Change
Revenue	$	156,667	100.0	%	$	153,614	100.0	%	$	3,053	2.0	%
Cost of sales	112,765		72.0	%	113,548		73.9	%	(783)		(0.7)	%
Gross profit	43,902		28.0	%	40,066		26.1	%	3,836		9.6	%
Selling, general and administrative expenses	33,251		21.2	%	25,591		16.7	%	7,660		29.9	%
Amortization of intangible assets	31		—	%	50		—	%	(19)		(38.0)	%
Operating profit (loss)	10,620		6.8	%	14,425		9.4	%	(3,805)		(26.4)	%
Interest expense, net	59		—	%	592		0.4	%	(533)		(90.0)	%
Pension termination expense	7,595		4.8	%	—		—	%	7,595		n/m
Other expense (income), net	298		0.2	%	645		0.4	%	(347)		(53.8)	%
Income (loss) before income taxes	2,668		1.7	%	13,188		8.6	%	(10,520)		(79.8)	%
Income tax expense (benefit)	732		0.5	%	2,848		1.9	%	(2,116)		(74.3)	%
Net income (loss)	$	1,936	1.2	%	$	10,340	6.7	%	$	(8,404)	(81.3)	%


Effective income tax rate			27.4		%										21.6		%

The following table identifies the components of the change in revenue:


	Revenue
2023	$	153,614
Increase (decrease) from:
Unit volume and product mix	8,425
Average sales price	(4,029)
Foreign currency	(1,343)
2024	$	156,667

Revenue - Revenue increased $3.1 million compared to the prior year due to a more favorable product mix and increased unit volume primarily driven by increased revenue in the US Consumer and Mexican Consumer markets. Additionally, the acquisition of HealthBeacon added a new revenue stream during the year and contributed $1.2 million in revenue for the three months ended September 30, 2024. These increases were partially offset by decreased revenue in the Latin American, Canadian Consumer, and Global Commercial markets.

Gross profit - As a percentage of revenue, gross profit margin increased to 28.0% compared to 26.1% in the prior year primarily due to a favorable product mix and lower product costs.

Table of Contents

Selling, general and administrative expenses (SG&A) - Selling, general and administrative expenses increased by $7.7 million compared to the third quarter of 2023. The increase was primarily driven by higher employee-related costs, including $2.9 million of increased non-cash equity incentive compensation due to stock price appreciation, the addition of $1.8 million of HealthBeacon SG&A expenses, and the absence of a $0.9 million non-recurring insurance recovery in the prior year.

Interest expense, net - Interest expense, net decreased $0.5 million due to decreased average borrowings outstanding under the HBB Facility and lower interest rates compared to the third quarter of 2023.

Pension termination expense - During the third quarter of 2024, a one-time non-cash expense of $7.6 million was incurred in connection with the termination of the Company’s U.S. defined benefit pension plan related to the reclassification of historical unrecognized losses from Accumulated Other Comprehensive Income.

Other expense (income), net - Other expense (income), net includes currency losses of $0.2 million in the current year compared to currency losses of $0.4 million in the prior year.

Income tax expense (benefit) - The effective tax rate was 27.4% and 21.6% for three months ended September 30, 2024 and 2023, respectively. The effective tax rate was higher in the three months ended September 30, 2024 due to a valuation allowance on foreign losses in the current year and a tax benefit on foreign income in the prior year that did not recur.

First Nine Months of 2024 Compared with First Nine Months of 2023


	NINE MONTHS ENDED SEPTEMBER 30
	2024		% of Revenue		2023		% of Revenue		$ Change		% Change
Revenue	$	441,184	100.0	%	$	418,975	100.0	%	$	22,209	5.3	%
Cost of sales	326,732		74.1	%	330,583		78.9	%	(3,851)		(1.2)	%
Gross profit	114,452		25.9	%	88,392		21.1	%	26,060		29.5	%
Selling, general and administrative expenses	94,595		21.4	%	78,150		18.7	%	16,445		21.0	%
Amortization of intangible assets	224		0.1	%	150		—	%	74		49.3	%
Operating profit (loss)	19,633		4.5	%	10,092		2.4	%	9,541		94.5	%
Interest expense, net	330		0.1	%	2,634		0.6	%	(2,304)		(87.5)	%
Pension termination expense	7,595		1.7	%	—		—	%	7,595		n/m
Other expense (income), net	1,354		0.3	%	390		0.1	%	964		247.2	%
Income (loss) before income taxes	10,354		2.3	%	7,068		1.7	%	3,286		46.5	%
Income tax expense (benefit)	3,594		0.8	%	1,395		0.3	%	2,199		157.6	%
Net income (loss)	$	6,760	1.5	%	$	5,673	1.4	%	$	1,087	19.2	%


Effective income tax rate			34.7		%										19.7		%

The following table identifies the components of the change in revenue:


	Revenue
2023	$	418,975
Increase (decrease) from:
Unit volume and product mix	46,765
Average sales price	(24,249)
Foreign currency	(307)
2024	$	441,184

Revenue - Revenue increased by $22.2 million compared to the prior year due to increased unit volume and a more favorable product mix primarily driven by increased revenue in the US Consumer, Mexico Consumer, and Latin American markets. Additionally, the acquisition of HealthBeacon added a new revenue stream during the year and contributed $2.6 million in revenue for the nine months ended September 30, 2024. These increases were partially offset by decreased revenue in the Canadian Consumer market and Global Commercial market.

Table of Contents

Gross profit - Gross profit margin increased to 25.9% from 21.1% primarily due to lower product costs and a favorable product mix.

Selling, general and administrative expenses (SG&A) - Selling, general and administrative expenses increased $16.4 million compared to 2023. The increase is primarily due to the addition of $5.6 million of HealthBeacon SG&A expenses, higher employee-related costs, including $4.2 million of increased non-cash equity incentive compensation due to stock price appreciation, an increase in outside services and non-recurring items, which include $1.3 million of HealthBeacon transaction costs and the absence of a $0.9 million insurance recovery that occurred in the prior year.

Interest expense, net - Interest expense, net decreased $2.3 million due to decreased average borrowings outstanding under the HBB Facility, and lower interest rates compared to 2023.

Other expense (income), net - Other expense (income), net includes currency losses of $0.8 million in the current year compared to currency gains of $0.1 million in the prior year.

Income tax expense (benefit) - The effective tax rate was 34.7% compared to 19.7% in the prior year. The effective tax rate was higher for the nine months ended September 30, 2024 due to a valuation allowance on foreign losses in the current year and tax benefits on foreign income and credits in the prior year that did not recur.

LIQUIDITY AND CAPITAL RESOURCES

Liquidity

Our cash flows are provided by dividends paid or distributions made by HBB. The only material assets held by us are the investment in our consolidated subsidiary. As a result, certain statutory limitations or regulatory or financing agreements could affect the levels of distributions allowed to be made by our subsidiary. We have not guaranteed any of the obligations of HBB.

Our principal sources of cash to fund liquidity needs are: (1) cash generated from operations and (2) borrowings available under the HBB Facility. Our primary use of funds consists of working capital requirements, operating expenses, payment of dividends, repurchase of shares, capital expenditures, payments of principal and interest on debt and acquisitions.

The HBB Facility expires on June 30, 2025, within one year after the issuance of these financial statements. We have not yet completed our refinancing of the HBB Facility and, accordingly, all amounts outstanding have been classified as current liabilities. Based on the status of the refinancing and our history of successfully refinancing our debt, we believe that it is probable that the HBB Facility will be refinanced before its maturity. We believe funds available from cash on hand, the HBB Facility and operating cash flows will provide sufficient liquidity to meet our operating needs and commitments arising during the next twelve months.

The following table presents selected cash flow information:


	NINE MONTHS ENDED SEPTEMBER 30
	2024		2023
Net cash provided by (used for) operating activities	$	35,177	$	68,683
Net cash provided by (used for) investing activities	$	(13,038)	$	(2,436)
Net cash provided by (used for) financing activities	$	(14,593)	$	(65,669)

Operating activities - Net cash provided by operating activities was $35.2 million, representing more normalized post-pandemic working capital, compared to $68.7 million in the prior year, which benefited from significant excess inventory reduction activities. Net working capital provided cash of $20.3 million in 2024 compared to cash provided of $64.3 million in 2023. The 2024 period benefited from the Company's continued focus on working capital management which led to improvements in days sales outstanding and days payable outstanding. The change in net cash provided by operating activities reflects the net working capital changes partially offset by adjustments to net income for the non-cash stock compensation and pension termination expenses.

Table of Contents

Investing activities - Net cash used for investing activities in 2024 increased compared to 2023 related primarily to the acquisition of HealthBeacon offset by the extinguishment of our secured loan to HealthBeacon in the first quarter of 2024 which provided net cash of $1.6 million. Additionally, the Company used excess cash on hand to invest in a six-month U.S. Treasury bill during the third quarter of 2024.

Financing activities - Net cash used for financing activities was $14.6 million in 2024 compared to net cash used for financing activities of $65.7 million in 2023. The change is due to a decrease in HBB’s net borrowing activity on the HBB Facility. This decrease was partially offset by increased purchases of treasury stock.

Capital Resources

The HBB Facility expires on June 30, 2025. The entire outstanding balance has been classified as a current liability due to the fact the facility expires within one year and has not yet been refinanced. The Company does not expect to make voluntary repayments under the HBB Facility as the rate of return to invest excess cash exceeds the average interest rate of the HBB Facility. A material decrease in interest rates could cause us to re-evaluate.

The obligations under the HBB Facility are secured by substantially all of HBB’s assets. As of September 30, 2024, the borrowing base under the HBB Facility was $148.5 million and borrowings outstanding were $50.0 million. As of September 30, 2024, the excess availability under the HBB Facility was $98.5 million.

The maximum availability under the HBB Facility is governed by a borrowing base derived from advance rates against eligible trade receivables, inventory and trademarks of the borrowers, as defined in the HBB Facility. Borrowings bear interest at a floating rate, which can be a base rate, SOFR or bankers’ acceptance rate, as defined in the HBB Facility, plus an applicable margin. The applicable margins, effective September 30, 2024, for base rate loans and SOFR loans denominated in U.S. dollars were 0.0% and 1.55%, respectively. The applicable margins, effective September 30, 2024, for base rate loans and bankers’ acceptance loans denominated in Canadian dollars were 0.0% and 1.55%, respectively. The HBB Facility also requires a fee of 0.25% per annum on the unused commitment. The margins and unused commitment fee under the HBB Facility are subject to quarterly adjustment based on average excess availability. The weighted average interest rate applicable to the HBB Facility for the nine months ended September 30, 2024 was 3.18% including the floating rate margin and the effect of the interest rate swap agreements described below.

To reduce the exposure to changes in the market rate of interest, we have entered into interest rate swap agreements for a portion of the HBB Facility. Terms of the interest rate swap agreements require us to receive a variable interest rate and pay a fixed interest rate. We have interest rate swaps with notional values totaling $50.0 million as of September 30, 2024 at an average fixed interest rate of 1.59%.

The HBB Facility includes restrictive covenants, which, among other things, limit the payment of dividends, subject to achieving availability thresholds. Dividends are not to exceed $7.0 million during any calendar year to the extent that for the thirty days prior to the dividend payment date, and after giving effect to the dividend payment, HBB maintains excess availability of at least $18.0 million. Dividend amounts are discretionary to the extent that for the thirty days prior to the dividend payment date, and after giving effect to the dividend payment, HBB maintains excess availability of at least $30.0 million. The HBB Facility also requires the Company to achieve a minimum fixed charge coverage ratio in certain circumstances, as defined in the HBB Facility. As of September 30, 2024, we were in compliance with all financial covenants in the HBB Facility.

In December 2015, the Company entered into an arrangement with a financial institution to sell certain U.S. trade receivables on a non-recourse basis. See Note 2 of the unaudited consolidated financial statements.

Contractual Obligations, Contingent Liabilities and Commitments

For a summary of the Company’s contractual obligations, contingent liabilities and commitments, refer to “Part II - Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations - Contractual Obligations, Contingent Liabilities and Commitments” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, as there have been no material changes from those disclosed in the Annual Report.

Table of Contents

Off Balance Sheet Arrangements

For a summary of the Company’s off balance sheet arrangements, refer to “Part II - Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations - Off Balance Sheet Arrangements” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, as there have been no material changes from those disclosed in the Annual Report.

FORWARD-LOOKING STATEMENTS

The statements contained in this Form 10-Q that are not historical facts are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Exchange Act. These forward-looking statements are made subject to certain risks and uncertainties, which could cause actual results to differ materially from those presented. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof. Such risks and uncertainties include, without limitation: (1) uncertain or unfavorable global economic conditions and impacts from global military conflicts; (2) the Company’s ability to source and ship products to meet anticipated demand; (3) the Company’s ability to successfully manage constraints throughout the global transportation supply chain; (4) changes in the sales prices, product mix or levels of consumer purchases of small electric and specialty housewares appliances; (5) changes in consumer retail and credit markets, including the increasing volume of transactions made through third-party internet sellers; (6) bankruptcy of or loss of major retail customers or suppliers; (7) changes in costs, including transportation costs, of sourced products; (8) delays in delivery of sourced products; (9) changes in or unavailability of quality or cost effective suppliers; (10) exchange rate fluctuations, changes in the import tariffs and monetary policies and other changes in the regulatory climate in the countries in which the Company operates or buys and/or sells products; (11) the impact of tariffs on customer purchasing patterns; (12) product liability, regulatory actions or other litigation, warranty claims or returns of products; (13) customer acceptance of, changes in costs of or delays in the development of new products; (14) increased competition, including consolidation within the industry; (15) changes in customers’ inventory management strategies; (16) shifts in consumer shopping patterns, gasoline prices, weather conditions, the level of consumer confidence and disposable income as a result of economic conditions, unemployment rates or other events or conditions that may adversely affect the level of customer purchases of the Company’s products; (17) changes mandated by federal, state and other regulation, including tax, health, safety or environmental legislation; (18) the Company’s ability to identify, acquire or develop, and successfully integrate, new businesses or new product lines; and (19) other risk factors, including those described in the Company’s filings with the Securities and Exchange Commission, including, but not limited to, the Annual Report on Form 10-K for the year ended December 31, 2023. Furthermore, the future impact of unfavorable economic conditions, including inflation, changing interest rates, availability of capital markets and consumer spending rates remains uncertain. In uncertain economic environments, we cannot predict whether or when such circumstances may improve or worsen, or what impact, if any, such circumstances could have on our business, results of operations, cash flows and financial position.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

INTEREST RATE RISK

We enter into certain financing arrangements that require interest payments based on floating interest rates. As such, our financial results are subject to changes in the market rate of interest. There is an inherent rollover risk for borrowings as they mature and are renewed at current market rates. The extent of this risk is not quantifiable or predictable because of the variability of future interest rates and business financing requirements. To reduce the exposure to changes in the market rate of interest, we have entered into interest rate swap agreements for a portion of our floating rate financing arrangements. We do not enter into interest rate swap agreements for trading purposes. Terms of the interest rate swap agreements require us to receive a variable interest rate and pay a fixed interest rate.

For the purpose of risk analysis, we use sensitivity analysis to measure the potential loss in fair value of financial instruments sensitive to changes in interest rates. We assume that a loss in fair value is an increase in our receivables. The fair value of the Company’s interest rate swap agreements was an asset of $2.9 million as of September 30, 2024. A hypothetical 10% relative decrease in interest rates would cause a decrease of $0.2 million in the fair value of interest rate swap agreements. Additionally, a hypothetical 10% relative increase in interest rates would cause an increase of $0.2 million in the fair value of interest rate swap agreements. Neither would have a material impact to the Company’s interest expense, net of $0.3 million for the nine months ended September 30, 2024.

Table of Contents

FOREIGN CURRENCY EXCHANGE RATE RISK

We operate internationally through our foreign operating subsidiaries and enters into transactions denominated in foreign currencies, principally the Canadian dollar, the Mexican peso and, to a lesser extent, the Chinese yuan, Brazilian real and the European Union euro. As such, our financial results are subject to the variability that arises from exchange rate movements. The fluctuation in the value of the U.S. dollar against other currencies affects the reported amounts of revenues, expenses, assets and liabilities. The potential impact of currency fluctuation increases as international expansion increases.

We use forward foreign currency exchange contracts to partially reduce risks related to transactions denominated in foreign currencies and not for trading purposes. These contracts generally mature within twelve months and require us to buy or sell the functional currency in which the applicable subsidiary operates and buy or sell U.S. dollars at rates agreed to at the inception of the contracts.

For the purpose of risk analysis, we use sensitivity analysis to measure the potential loss in fair value of financial instruments sensitive to changes in foreign currency exchange spot rates. We assume that a loss in fair value is either a decrease to our assets or an increase to our liabilities. The fair value of our foreign currency exchange contracts was a net receivable of $0.5 million as of September 30, 2024. Assuming a hypothetical 10% weakening of the U.S. dollar as of September 30, 2024, the fair value of foreign currency-sensitive financial instruments, which represents forward foreign currency exchange contracts, would be decreased by $1.2 million compared with its fair value as of September 30, 2024.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Company management, with the participation of the Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of the Company’s disclosure controls and procedures as of September 30, 2024. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that the Company’s disclosure controls and procedures were effective as of September 30, 2024.

Changes in Internal Control Over Financial Reporting

There were no changes, except as noted below, in the Company’s internal control over financial reporting identified during the quarter ended September 30, 2024, in connection with the evaluation by the Company’s management required by paragraph (d) of Rules 13a-15 and 15d-15 under the Exchange Act, that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

On February 2, 2024, we acquired HealthBeacon, as discussed in Note 8: Acquisitions in Part I, Item 1 in this Quarterly Report on Form 10-Q. We are currently integrating HealthBeacon into our operations and internal control processes, and, as permitted by the SEC rules and regulations, we have not yet included HealthBeacon in our assessment of the effectiveness of our internal control over financial reporting. We anticipate HealthBeacon will be included in management’s evaluation of internal control over financial reporting as of December 31, 2025.

Table of Contents

PART II

OTHER INFORMATION

Item 1 Legal Proceedings

The information required by this Item 1 is set forth in Note 6 “Contingencies” included in the unaudited consolidated financial statements contained in Part I of this Form 10-Q and is hereby incorporated herein by reference to such information.

Item 1A Risk Factors

There are no material changes to the risk factors for the Company from those disclosed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023.

Item 2 Unregistered Sales of Equity Securities and Use of Proceeds


Issuer Purchases of Equity Securities (1)
	(a)	(b)		(c)	(d)
Period	Total Number of Shares Purchased	Average Price Paid per Share		Total Number of Shares Purchased as Part of the Publicly Announced Program	Maximum Dollar Value of Shares that May Yet Be Purchased Under the Program
Month #1 July 1 to 31, 2024	79,788	$	18.36	79,788	$	19,550,595
Month #2 August 1 to 31, 2024	91,484	$	26.54	91,484	$	17,122,631
Month #3 September 1 to 30, 2024	50,257	$	28.52	50,257	$	15,689,476
	221,529	$	24.04	221,529	$	15,689,476

(1) In November 2023, the Company’s Board approved a stock repurchase program for the purchase of up to $25 million of the Company’s Class A Common outstanding starting January 1, 2024 and ending December 31, 2025.

During the three and nine months ended September 30, 2024, the Company repurchased 221,529 and 441,741 shares, respectively, at prevailing market prices for an aggregate purchase price of $5.3 million and $9.3 million, respectively. During the three and nine months ended September 30, 2023, the Company repurchased 82,676 and 139,649 shares, respectively, at prevailing market prices for an aggregate purchase price of $0.9 million and $1.5 million, respectively. During the year ended December 31, 2023, the Company repurchased 250,772 shares for an aggregate purchase price of $3.1 million.

Item 3 Defaults Upon Senior Securities

None.

Item 4 Mine Safety Disclosures

None.

Item 5 Other Information

None of the Company’s directors or "officers" (as defined in Rule 16a-1(f) promulgated under the Exchange Act) adopted, modified, or terminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408 of Regulation S-K, during the Company's fiscal quarter ended September 30, 2024.

Table of Contents

Item 6 Exhibits


Exhibit
Number*						Description of Exhibits

31(i)(1)						Certification of R. Scott Tidey pursuant to Rule 13a-14(a)/15d-14(a) of the Exchange Act
31(i)(2)						Certification of Sally M. Cunningham pursuant to Rule 13a-14(a)/15d-14(a) of the Exchange Act
32						Certifications pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, signed and dated by R. Scott Tidey and Sally M. Cunningham
101.INS						Inline XBRL Instance Document
101.SCH						Inline XBRL Taxonomy Extension Schema Document
101.CAL						Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF						Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB						Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE						Inline XBRL Taxonomy Extension Presentation Linkbase Document
104						Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

* Numbered in accordance with Item 601 of Regulation S-K.

Table of Contents

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


		Hamilton Beach Brands Holding Company (Registrant)
Date:	October 30, 2024	/s/ Sally M. Cunningham
		Sally M. Cunningham
		Senior Vice President, Chief Financial Officer and Treasurer (Principal Financial Officer)/(Principal Accounting Officer)

Exhibit 31(i)(1)

Certifications

I, R. Scott Tidey, certify that:

1.I have reviewed this quarterly report on Form 10-Q of Hamilton Beach Brands Holding Company;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.


Date:	October 30, 2024	/s/ R. Scott Tidey
		R. Scott Tidey
		President and Chief Executive Officer (Principal Executive Officer)

Exhibit 31(i)(2)

Certifications

I, Sally M. Cunningham, certify that:

1.I have reviewed this quarterly report on Form 10-Q of Hamilton Beach Brands Holding Company;

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.


Date:	October 30, 2024	/s/ Sally M. Cunningham
		Sally M. Cunningham
		Senior Vice President, Chief Financial Officer and Treasurer (Principal Financial Officer)/(Principal Accounting Officer)

Exhibit 32

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Hamilton Beach Holding Company (the “Company”) on Form 10-Q for the quarter ended September 30, 2024, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned officers of the Company certifies, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to such officer’s knowledge:

(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of the dates and for the periods expressed in the Report.


Date:	October 30, 2024	/s/ R. Scott Tidey
		R. Scott Tidey
		President and Chief Executive Officer (Principal Executive Officer)

Date:	October 30, 2024	/s/ Sally M. Cunningham
		Sally M. Cunningham
		Senior Vice President, Chief Financial Officer and Treasurer (Principal Financial Officer)/(Principal Accounting Officer)

Cover Page - shares	9 Months Ended
Cover Page - shares	Sep. 30, 2024	Oct. 25, 2024
Entity Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2024
Document Transition Report	false
Entity File Number	001-38214
Entity Registrant Name	HAMILTON BEACH BRANDS HOLDING COMPANY
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	31-1236686
Entity Address, Address Line One	4421 WATERFRONT DR.
Entity Address, City or Town	GLEN ALLEN
Entity Address, State or Province	VA
Entity Address, Postal Zip Code	23060
City Area Code	(804)
Local Phone Number	273-9777
Title of 12(b) Security	Class A Common Stock, Par Value $0.01 Per Share
Trading Symbol	HBB
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Central Index Key	0001709164
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q3
Amendment Flag	false
Class A Common stock
Entity Information [Line Items]
Entity Common Stock, Shares Outstanding		10,098,373
Class B Common stock
Entity Information [Line Items]
Entity Common Stock, Shares Outstanding		3,606,543

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023	Sep. 30, 2023
Current assets
Cash and cash equivalents	$ 22,602	$ 15,370	$ 1,624
Trade receivables, net	99,049	135,434	102,178
Inventory	164,802	126,554	160,237
Prepaid expenses and other current assets	18,912	9,457	14,417
Total current assets	305,365	286,815	278,456
Property, plant and equipment, net	35,238	27,401	27,493
Right-of-use lease assets	36,627	39,423	40,590
Goodwill	7,099	6,253	6,253
Other intangible assets, net	2,179	1,292	1,342
Deferred income taxes	2,187	2,581	2,577
Deferred costs	15,434	14,613	14,419
Other non-current assets	4,540	6,324	7,790
Total assets	408,669	384,702	378,920
Current liabilities
Accounts payable	128,489	99,704	116,124
Revolving credit agreements	50,000	0	0
Accrued compensation	12,622	14,948	11,025
Accrued product returns	6,616	6,232	5,801
Lease liabilities	5,584	6,155	6,136
Other current liabilities	10,130	12,549	12,776
Total current liabilities	213,441	139,588	151,862
Revolving credit agreements	0	50,000	51,276
Lease liabilities, non-current	39,528	41,937	43,303
Other long-term liabilities	5,749	5,910	4,659
Total liabilities	258,718	237,435	251,100
Stockholders’ equity
Preferred stock, par value $0.01 per share	0	0	0
Capital in excess of par value	77,779	70,401	68,180
Treasury stock	(21,878)	(12,013)	(10,409)
Retained earnings	101,430	99,398	81,362
Accumulated other comprehensive loss	(7,531)	(10,667)	(11,461)
Total stockholders’ equity	149,951	147,267	127,820
Total liabilities and stockholders’ equity	408,669	384,702	378,920
Class A Common stock
Stockholders’ equity
Common stock	115	112	112
Class B Common stock
Stockholders’ equity
Common stock	$ 36	$ 36	$ 36

CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Sep. 30, 2024	Dec. 31, 2023	Sep. 30, 2023
Statement of Financial Position [Abstract]
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01	$ 0.01

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Income Statement [Abstract]
Revenue	$ 156,667	$ 153,614	$ 441,184	$ 418,975
Cost of sales	112,765	113,548	326,732	330,583
Gross profit	43,902	40,066	114,452	88,392
Selling, general and administrative expenses	33,251	25,591	94,595	78,150
Amortization of intangible assets	31	50	224	150
Operating profit (loss)	10,620	14,425	19,633	10,092
Interest expense, net	59	592	330	2,634
Pension termination expense	7,595	0	7,595	0
Other expense (income), net	298	645	1,354	390
Income (loss) before income taxes	2,668	13,188	10,354	7,068
Income tax expense (benefit)	732	2,848	3,594	1,395
Net income (loss)	$ 1,936	$ 10,340	$ 6,760	$ 5,673
Basic earnings (loss) per share (in dollars per share)	$ 0.14	$ 0.74	$ 0.48	$ 0.40
Diluted earnings (loss) per share (in dollars per share)	$ 0.14	$ 0.74	$ 0.48	$ 0.40
Basic weighted average shares outstanding (in shares)	13,852	14,025	14,042	14,060
Diluted weighted average shares outstanding (in shares)	13,863	14,050	14,056	14,085

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Statement of Comprehensive Income [Abstract]
Net income (loss)	$ 1,936	$ 10,340	$ 6,760	$ 5,673
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustment	(516)	(661)	(3,481)	(182)
(Loss) gain on long-term intra-entity foreign currency transactions	0	0	0	653
Cash flow hedging activity	(741)	249	851	(1,213)
Reclassification of hedging activities into earnings	(237)	473	(756)	1,002
Pension plan adjustment	695	0	695	0
Reclassification related to pension termination activity into earnings	5,658	0	5,658	0
Reclassification of pension adjustments into earnings	37	73	169	197
Total other comprehensive income (loss), net of tax	4,896	134	3,136	457
Comprehensive income (loss)	$ 6,832	$ 10,474	$ 9,896	$ 6,130

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Operating activities
Net income (loss)	$ 6,760	$ 5,673
Adjustments to reconcile net income (loss) to net cash provided by (used for) operating activities:
Depreciation and amortization	3,744	3,078
Stock compensation expense	7,381	3,175
Pension termination expense	7,595	0
Other	3,206	(172)
Net changes in operating assets and liabilities:
Trade receivables	34,599	13,678
Inventory	(43,687)	(3,379)
Other assets	(3,321)	2,333
Accounts payable	29,425	54,013
Other liabilities	(10,525)	(9,716)
Net cash provided by (used for) operating activities	35,177	68,683
Investing activities
Expenditures for property, plant and equipment	(2,347)	(2,286)
Acquisition of business, net of cash acquired	(7,412)	0
Issuance of secured loan	(600)	0
Repayment of secured loan	2,205	0
Purchase of U.S. Treasury bill	(4,884)	0
Other	0	(150)
Net cash provided by (used for) investing activities	(13,038)	(2,436)
Financing activities
Net additions (reductions) to revolving credit agreements	0	(59,650)
Purchase of treasury stock	(9,865)	(1,470)
Cash dividends paid	(4,728)	(4,549)
Net cash provided by (used for) financing activities	(14,593)	(65,669)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(390)	81
Cash, cash equivalents and restricted cash
Increase (decrease) for the period	7,156	659
Balance at the beginning of the period	16,379	1,905
Balance at the end of the period	23,535	2,564
Reconciliation of cash, cash equivalents and restricted cash
Cash and cash equivalents	22,602	1,624
Restricted cash included in prepaid expenses and other current assets	63	24
Restricted cash included in other non-current assets	870	916
Total cash, cash equivalents and restricted cash	$ 23,535	$ 2,564

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($) $ in Thousands	Total	Common Stock Class A Common stock	Common Stock Class B Common stock	Capital in Excess of Par Value	Treasury Stock	Retained Earnings	Accumulated Other Comprehensive Income (Loss)
Beginning balance at Dec. 31, 2022	$ 124,534	$ 107	$ 38	$ 65,008	$ (8,939)	$ 80,238	$ (11,918)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(4,777)					(4,777)
Issuance of common stock, net of conversions	0	4	(2)	(2)
Share-based compensation expense	797			797
Cash dividends	(1,460)					(1,460)
Other comprehensive income (loss), net of tax	(916)						(916)
Reclassification adjustment to net income (loss)	251						251
Ending balance at Mar. 31, 2023	118,429	111	36	65,803	(8,939)	74,001	(12,583)
Beginning balance at Dec. 31, 2022	124,534	107	38	65,008	(8,939)	80,238	(11,918)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	5,673
Ending balance at Sep. 30, 2023	127,820	112	36	68,180	(10,409)	81,362	(11,461)
Beginning balance at Mar. 31, 2023	118,429	111	36	65,803	(8,939)	74,001	(12,583)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	110					110
Purchase of treasury stock	(575)				(575)
Share-based compensation expense	962			962
Cash dividends	(1,548)					(1,548)
Other comprehensive income (loss), net of tax	586						586
Reclassification adjustment to net income (loss)	402						402
Ending balance at Jun. 30, 2023	118,366	111	36	66,765	(9,514)	72,563	(11,595)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	10,340					10,340
Purchase of treasury stock	(895)				(895)
Issuance of common stock, net of conversions	0	1		(1)
Share-based compensation expense	1,416			1,416
Cash dividends	(1,541)					(1,541)
Other comprehensive income (loss), net of tax	(412)						(412)
Reclassification adjustment to net income (loss)	546						546
Ending balance at Sep. 30, 2023	127,820	112	36	68,180	(10,409)	81,362	(11,461)
Beginning balance at Dec. 31, 2023	147,267	112	36	70,401	(12,013)	99,398	(10,667)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(1,162)					(1,162)
Purchase of treasury stock	(554)				(554)
Issuance of common stock, net of conversions	0	2		(2)
Share-based compensation expense	1,904			1,904
Cash dividends	(1,531)					(1,531)
Other comprehensive income (loss), net of tax	(1,060)						(1,060)
Reclassification adjustment to net income (loss)	543						543
Ending balance at Mar. 31, 2024	145,407	114	36	72,303	(12,567)	96,705	(11,184)
Beginning balance at Dec. 31, 2023	147,267	112	36	70,401	(12,013)	99,398	(10,667)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	6,760
Ending balance at Sep. 30, 2024	149,951	115	36	77,779	(21,878)	101,430	(7,531)
Beginning balance at Mar. 31, 2024	145,407	114	36	72,303	(12,567)	96,705	(11,184)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	5,986					5,986
Purchase of treasury stock	(3,985)				(3,985)
Share-based compensation expense	1,180			1,180
Cash dividends	(1,613)					(1,613)
Other comprehensive income (loss), net of tax	(313)						(313)
Reclassification adjustment to net income (loss)	(930)						(930)
Ending balance at Jun. 30, 2024	145,732	114	36	73,483	(16,552)	101,078	(12,427)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	1,936					1,936
Purchase of treasury stock	(5,326)				(5,326)
Issuance of common stock, net of conversions	0	1		(1)
Share-based compensation expense	4,297			4,297
Cash dividends	(1,584)					(1,584)
Other comprehensive income (loss), net of tax	(562)						(562)
Reclassification adjustment to net income (loss)	5,458						5,458
Ending balance at Sep. 30, 2024	$ 149,951	$ 115	$ 36	$ 77,779	$ (21,878)	$ 101,430	$ (7,531)

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (Parenthetical) - $ / shares	3 Months Ended
	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023
Statement of Stockholders' Equity [Abstract]
Cash dividends (in dollars per share)	$ 0.115	$ 0.115	$ 0.11	$ 0.11	$ 0.11	$ 0.105

Basis of Presentation and Recently Issued Accounting Standards	9 Months Ended
	Sep. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation and Recently Issued Accounting Standards	Basis of Presentation and Recently Issued Accounting Standards Basis of Presentation Throughout this Quarterly Report on Form 10-Q and the notes to unaudited consolidated financial statements, references to “Hamilton Beach Holding”, “the Company”, “we”, “us” and “our” and similar references are to Hamilton Beach Brands Holding Company and its subsidiaries on a consolidated basis unless otherwise noted or as the context otherwise requires. Hamilton Beach Brands Holding Company is a holding company and operates through its indirect, wholly owned subsidiary, Hamilton Beach Brands, Inc., a Delaware corporation (“HBB”). HBB is the Company’s single reportable segment. We are a leading designer, marketer and distributor of a wide range of branded small electric household and specialty housewares appliances, as well as commercial products for restaurants, fast food chains, bars and hotels, and are a provider of connected devices and software for healthcare management. The financial statements have been prepared in accordance with U.S. generally accepted accounting principles (GAAP) for interim financial information. Accordingly, they do not include all of the information and notes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments of a normal recurring nature considered necessary for a fair presentation have been included. These financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023. Operating results for the nine months ended September 30, 2024 are not necessarily indicative of the results that may be expected for the remainder of the year due to the highly seasonal nature of the Company’s primary markets. A majority of revenue and operating profit typically occurs in the second half of the calendar year when sales of products to retailers and consumers historically increase significantly for the fall holiday-selling season. We maintain a $150.0 million senior secured floating-rate revolving credit facility (the “HBB Facility”) that expires on June 30, 2025, within one year after the issuance of these financial statements. We have not yet completed our refinancing of the HBB Facility and, accordingly, all amounts outstanding have been classified as current liabilities. Based on the status of the refinancing and our history of successfully refinancing our debt, we believe that it is probable that the HBB Facility will be refinanced before its maturity. We believe funds available from cash on hand, the HBB Facility and operating cash flows will provide sufficient liquidity to meet our operating needs and commitments arising during the next twelve months. Accounting Standards Not Yet Adopted In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures,” which updates reportable segment disclosure requirements on an annual and interim basis. The amendments are effective for the annual period ending December 31, 2024, and the interim periods thereafter. Early adoption is permitted. Updates should be applied retrospectively to all prior periods presented in the financial statements. Adoption of this ASU may result in additional disclosure, but it will not impact the Company’s consolidated financial position, results of operations or cash flows. In December 2023, the FASB issued ASU 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures,” which enhances income tax disclosure requirements primarily involving more detailed disclosure for income taxes paid and the effective tax rate reconciliation. The amendments are effective for annual periods beginning after December 15, 2024. Early adoption is permitted. The amendments should be applied prospectively but retrospective application is permitted. Adoption of this ASU may result in additional disclosure, but it will not impact the Company’s consolidated financial position, results of operations or cash flows. U.S. Pension Plan Termination During 2022, the Board approved the termination of our U.S. defined benefit pension plan (the “U.S. Pension Plan”) with an effective date of September 30, 2022. During the third quarter of 2024, the Company remeasured the U.S. Pension Plan since benefit obligations were settled through a combination of lump sum payments to eligible plan participants and the purchase of a group annuity contract in August 2024, under which future benefit obligations were transferred to a third-party insurance company. The remaining benefit obligations through October 2024 will be settled during the fourth quarter of 2024. The remaining balance as of September 30, 2024 is a deferred loss of $0.1 million within Accumulated Other Comprehensive Income. The Company currently expects that all surplus assets remaining after the U.S. Pension Plan termination will be transferred to a qualified replacement plan once all remaining benefit obligations are settled. The surplus assets as of the remeasurement date of August 31, 2024 were $13.3 million which are included within prepaid expenses and other current assets on the Consolidated Balance Sheets. The remeasurement resulted in pre-tax settlement charges of $7.6 million ($5.7 million post-tax) during the three months ended September 30, 2024, which were released from Accumulated Other Comprehensive Income into earnings and are included within Pension termination expense on the Consolidated Statements of Operations. Accounts payable - Supplier Finance Program The Company has an agreement with a third-party administrator to provide an accounts payable tracking system which facilitates a participating supplier’s ability to monitor and voluntarily elect to sell payment obligations owed by the Company to the designated third-party financial institution. Participating suppliers can sell one or more of the Company’s payment obligations at their sole discretion. The Company has no economic interest in a supplier’s decision to sell one or more of its payment obligations. The Company’s rights and obligations with respect to such payment obligations, including amounts due and scheduled payment terms, are not impacted by suppliers’ decisions to sell amounts under these arrangements. The agreement has a limit of $60.0 million in payment obligations ($85.0 million during peak season from August to January). There is no requirement to provide assets pledged as security or other forms of guarantees under the agreement. The Company pays the third-party administrator based upon the original payment terms negotiated with participating suppliers. The payment of these obligations by the Company is included in cash used in operating activities in the Consolidated Statement of Cash Flows. As of September 30, 2024, December 31, 2023 and September 30, 2023, the Company has $70.1 million, $55.0 million and $72.8 million, respectively, in outstanding payment obligations that are presented in Accounts payable on the Consolidated Balance Sheets. Of these totals, the third-party financial institution has made payments to participating suppliers to settle $60.8 million, $48.9 million and $63.8 million, respectively, of our outstanding payment obligations. U.S. Treasury Bills During the third quarter of 2024, the Company invested $9.8 million of excess cash on hand into two U.S. Treasury Bills with original maturities of three and six months. U.S. Treasury Bills with an original maturity of 3 months or less are included within cash and cash equivalents on the Consolidated Balance Sheets and those greater than 3 months but less than one year are included within prepaid expenses and other current assets on the Consolidated Balance Sheets. The Company has classified these U.S. Treasury Bills as held-to-maturity as it intends to hold these securities until maturity. Held-to-maturity debt securities are recorded at amortized cost. Discounts from and premiums to par value on held-to-maturity debt securities are accreted/amortized into interest income over the life of the respective security using the effective interest method. The Company evaluates for other than temporary impairment on an ongoing basis. No impairment has been recognized for investments in debt securities for any period presented. As of September 30, 2024, the amortized cost and net carrying value of the securities recognized in cash and cash equivalents and prepaid expenses and other current assets were $5.0 million and $4.9 million, respectively.

Transfer of Financial Assets	9 Months Ended
Transfer of Financial Assets	Sep. 30, 2024
Transfers and Servicing [Abstract]
Transfer of Financial Assets	Transfer of Financial Assets The Company has entered into an arrangement with a financial institution to sell certain U.S. trade receivables on a non-recourse basis. Under the terms of the agreement, the Company receives cash proceeds and retains no rights or interest and has no obligations with respect to the sold receivables. These transactions, which are accounted for as sold receivables, result in a reduction in trade receivables because the agreement transfers effective control over and risk related to the receivables to the buyer. Under this arrangement, the Company derecognized $33.5 million and $104.1 million of trade receivables during the three and nine months ending September 30, 2024, respectively, $30.7 million and $90.0 million of trade receivables during the three and nine months ending September 30, 2023, respectively, and $128.7 million during the year ending December 31, 2023. The loss incurred on sold receivables in the consolidated results of operations for the three and nine months ended September 30, 2024 and 2023 was not material. The Company does not carry any servicing assets or liabilities. Cash proceeds from this arrangement are reflected as operating activities in the Consolidated Statements of Cash Flows.

Fair Value Disclosure

9 Months Ended

Sep. 30, 2024

Fair Value Disclosures [Abstract]

Fair Value Disclosure

The following table presents the Company’s assets and liabilities accounted for at fair value on a recurring basis:


Description	Balance Sheet Location	SEPTEMBER 30 2024		DECEMBER 31 2023		SEPTEMBER 30 2023
Assets:
Interest rate swap agreements
Current	Prepaid expenses and other current assets	$	798	$	511	$	929
Long-term	Other non-current assets	2,141		3,501		4,977
Foreign currency exchange contracts
Current	Prepaid expenses and other current assets	614		—		87
		$	3,553	$	4,012	$	5,993
Liabilities:



Foreign currency exchange contracts
Current	Other current liabilities	77		538		331
		$	77	$	538	$	331

Other Fair Value Measurement Disclosures

There were no transfers into or out of Levels 1, 2 or 3 during the three and nine months ended September 30, 2024.

Stockholders’ Equity

9 Months Ended

Sep. 30, 2024

Equity [Abstract]

Stockholders’ Equity

Capital Stock

The following table sets forth the Company’s authorized capital stock information:


	SEPTEMBER 30 2024	DECEMBER 31 2023	SEPTEMBER 30 2023

Preferred stock, par value $0.01 per share
Preferred stock authorized	5,000	5,000	5,000
Preferred stock outstanding	—	—	—
Class A Common stock, par value $0.01 per share
Class A Common authorized	70,000	70,000	70,000
Class A Common issued (1)(2)	11,459	11,161	11,126
Treasury Stock (3)	1,349	877	766
Class B Common stock, par value $0.01 per share, convertible into Class A Common stock on a one-for-one basis
Class B Common authorized	30,000	30,000	30,000
Class B Common issued (1)	3,608	3,616	3,625

Accumulated Other Comprehensive Loss: The following table summarizes changes in accumulated other comprehensive loss by component and related tax effects for periods shown:


	Foreign Currency		Deferred Gain (Loss) on Cash Flow Hedging		Pension Plan Adjustment		Total

Balance, January 1, 2024	$	(6,412)	$	2,424	$	(6,679)	$	(10,667)
Other comprehensive income (loss)	(1,097)		29		—		(1,068)
Reclassification adjustment to net income (loss)	—		647		94		741
Tax effects	—		(167)		(23)		(190)
Balance, March 31, 2024	(7,509)		2,933		(6,608)		(11,184)
Other comprehensive income (loss)	(1,868)		2,104		—		236
Reclassification adjustment to net income (loss)	—		(1,325)		83		(1,242)
Tax effects	—		(215)		(22)		(237)
Balance, June 30, 2024	(9,377)		3,497		(6,547)		(12,427)
Other comprehensive income (loss)	(516)		(944)		932		(528)
Reclassification adjustment to net income (loss)	—		(310)		7,649		7,339
Tax effects	—		276		(2,191)		(1,915)
Balance, September 30, 2024	$	(9,893)	$	2,519	$	(157)	$	(7,531)

Balance, January 1, 2023	$	(8,924)	$	4,158	$	(7,152)	$	(11,918)
Other comprehensive income (loss)	715		(1,881)		—		(1,166)
Reclassification adjustment to net income (loss)	—		252		87		339
Tax effects	(194)		379		(23)		162
Balance, March 31, 2023	(8,403)		2,908		(7,088)		(12,583)
Other comprehensive income (loss)	425		(59)		—		366
Reclassification adjustment to net income (loss)	—		465		83		548
Tax effects	186		(89)		(23)		74
Balance, June 30, 2023	(7,792)		3,225		(7,028)		(11,595)
Other comprehensive income (loss)	(661)		329		—		(332)
Reclassification adjustment to net income (loss)	—		648		95		743
Tax effects	—		(255)		(22)		(277)
Balance, September 30, 2023	$	(8,453)	$	3,947	$	(6,955)	$	(11,461)

Revenue

9 Months Ended

Sep. 30, 2024

Revenue from Contract with Customer [Abstract]

Revenue

A description of revenue sources and performance obligations for the Company are as follows:

Consumer and Commercial product revenue

License revenue

Lease revenue

The Company leases connected devices to specialty pharmacy networks and pharmaceutical companies and is accounted for under Accounting Standards Codification 842, Leases as operating leases.

The following table sets forth Company’s revenue on a disaggregated basis for the three and nine months ended September 30:


	THREE MONTHS ENDED SEPTEMBER 30				NINE MONTHS ENDED SEPTEMBER 30
	2024		2023		2024		2023
Type of good or service:
Consumer products	$	141,862	$	138,849	$	394,397	$	374,842
Commercial products	12,041		13,159		39,914		40,234
Licensing	1,841		1,606		4,801		3,899
Leasing	923		—		2,072		—
Total revenues	$	156,667	$	153,614	$	441,184	$	418,975

Contingencies	9 Months Ended
Contingencies	Sep. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
Contingencies	Contingencies The Company is involved in various legal and regulatory proceedings and claims that have arisen in the ordinary course of business, including product liability, patent infringement, asbestos related claims, environmental and other claims. Although it is difficult to predict the ultimate outcome of these proceedings and claims, the Company believes the ultimate disposition of these matters will not have a material adverse effect on the financial condition, results of operation or cash flows of the Company. Any costs that the Company estimates will be paid as a result of these claims are accrued when the liability is considered probable and the amount of such costs can be reasonably estimated. If a range of amounts can be reasonably estimated and no amount within the range is a better estimate than any other amount, then the minimum of the range is accrued. The Company does not accrue liabilities when the likelihood that the liability has been incurred is probable but the amount cannot be reasonably estimated or when the liability is believed to be only reasonably possible or remote. For contingencies where an unfavorable outcome is probable or reasonably possible and which are material, the Company discloses the nature of the contingency and, in some circumstances, an estimate of the possible loss. Proceedings and claims asserted against the Company are subject to inherent uncertainties and unfavorable rulings could occur. If an unfavorable ruling were to occur, there exists the possibility of an adverse impact on the Company’s financial position and on the results of operations and cash flows for the period in which the ruling occurs, or in future periods. Environmental matters The Company is investigating or remediating historical environmental contamination at some current and former sites operated by the Company or by businesses it acquired. Based on the current stage of the investigation or remediation at each known site, the Company estimates the total investigation and remediation costs and the period of assessment and remediation activity required for each site. The estimate of future investigation and remediation costs is primarily based on variables associated with site clean-up, including, but not limited to, physical characteristics of the site, the nature and extent of the contamination and applicable regulatory programs and remediation standards. No assessment can fully characterize all subsurface conditions at a site. There is no assurance that additional assessment and remediation efforts will not result in adjustments to estimated remediation costs or the time frame for remediation at these sites. The Company’s estimates of investigation and remediation costs may change if it discovers contamination at additional sites or additional contamination at known sites, if the effectiveness of its current remediation efforts change, if applicable federal or state regulations change or if the Company’s estimate of the time required to remediate the sites changes. The Company’s current estimates may differ materially from original estimates. As of September 30, 2024, December 31, 2023 and September 30, 2023, the Company had accrued undiscounted obligations of $3.5 million, $3.4 million and $3.4 million, respectively, for environmental investigation and remediation activities. The Company estimates that it is reasonably possible that it may incur additional expenses in the range of zero to $1.7 million related to the environmental investigation and remediation at these sites. As of September 30, 2024, the Company has $0.9 million, classified as restricted cash, associated with reimbursement of environmental investigation and remediation costs from a responsible party in exchange for release from all future obligations for one site. Additionally, the Company has a $1.6 million asset associated with the reimbursement of costs associated with two sites.

Income Taxes	9 Months Ended
Income Taxes	Sep. 30, 2024
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The Company’s provision for income taxes for interim periods is determined using an estimate of its annual effective tax rate, adjusted for discrete items, if any, that arise during the period. Each quarter, the Company updates its estimate of the annual effective tax rate, and if the estimated annual effective tax rate changes, the Company makes a cumulative adjustment in such period. The effective tax rate was 27.4% and 21.6% for the three months ended September 30, 2024 and 2023, respectively. The effective tax rate was higher in the three months ended September 30, 2024 due to a valuation allowance on foreign losses in the current year and a tax benefit on foreign income in the prior year that did not recur. The effective tax rate was 34.7% and 19.7% for the nine months ended September 30, 2024 and 2023, respectively. The effective tax rate was higher for the nine months ended September 30, 2024 due to a valuation allowance on foreign losses in the current year and tax benefits on foreign income and credits in the prior year that did not recur.

Acquisitions

9 Months Ended

Sep. 30, 2024

Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]

Acquisitions

There were no adjustments as allowed within the measurement period during the three months ended September 30, 2024.

The following table presents the preliminary value of assets acquired and liabilities assumed and will be finalized pending completion of purchase accounting matters:


	Preliminary Fair Values as of February 2, 2024
Cash and cash equivalents	$	147


Current assets	1,452
Property, plant and equipment, net	6,634

Goodwill	847
Other intangible assets, net	1,111

Total assets acquired	10,191
Liabilities, current	2,016
Liabilities, non-current	616
Total liabilities acquired	2,632
Purchase Price	$	7,559

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
Pay vs Performance Disclosure - USD ($) $ in Thousands	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2024	Sep. 30, 2023
Pay vs Performance Disclosure
Net income (loss)	$ 1,936	$ 5,986	$ (1,162)	$ 10,340	$ 110	$ (4,777)	$ 6,760	$ 5,673

Insider Trading Arrangements	3 Months Ended
Insider Trading Arrangements	Sep. 30, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Basis of Presentation and Recently Issued Accounting Standards (Policies)	9 Months Ended
	Sep. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Basis of Presentation Throughout this Quarterly Report on Form 10-Q and the notes to unaudited consolidated financial statements, references to “Hamilton Beach Holding”, “the Company”, “we”, “us” and “our” and similar references are to Hamilton Beach Brands Holding Company and its subsidiaries on a consolidated basis unless otherwise noted or as the context otherwise requires. Hamilton Beach Brands Holding Company is a holding company and operates through its indirect, wholly owned subsidiary, Hamilton Beach Brands, Inc., a Delaware corporation (“HBB”). HBB is the Company’s single reportable segment. We are a leading designer, marketer and distributor of a wide range of branded small electric household and specialty housewares appliances, as well as commercial products for restaurants, fast food chains, bars and hotels, and are a provider of connected devices and software for healthcare management. The financial statements have been prepared in accordance with U.S. generally accepted accounting principles (GAAP) for interim financial information. Accordingly, they do not include all of the information and notes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments of a normal recurring nature considered necessary for a fair presentation have been included. These financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023. Operating results for the nine months ended September 30, 2024 are not necessarily indicative of the results that may be expected for the remainder of the year due to the highly seasonal nature of the Company’s primary markets. A majority of revenue and operating profit typically occurs in the second half of the calendar year when sales of products to retailers and consumers historically increase significantly for the fall holiday-selling season.
Accounting Standards Not Yet Adopted	Accounting Standards Not Yet Adopted In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures,” which updates reportable segment disclosure requirements on an annual and interim basis. The amendments are effective for the annual period ending December 31, 2024, and the interim periods thereafter. Early adoption is permitted. Updates should be applied retrospectively to all prior periods presented in the financial statements. Adoption of this ASU may result in additional disclosure, but it will not impact the Company’s consolidated financial position, results of operations or cash flows. In December 2023, the FASB issued ASU 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures,” which enhances income tax disclosure requirements primarily involving more detailed disclosure for income taxes paid and the effective tax rate reconciliation. The amendments are effective for annual periods beginning after December 15, 2024. Early adoption is permitted. The amendments should be applied prospectively but retrospective application is permitted. Adoption of this ASU may result in additional disclosure, but it will not impact the Company’s consolidated financial position, results of operations or cash flows.
Accounts payable - Supplier Finance Program	Accounts payable - Supplier Finance Program The Company has an agreement with a third-party administrator to provide an accounts payable tracking system which facilitates a participating supplier’s ability to monitor and voluntarily elect to sell payment obligations owed by the Company to the designated third-party financial institution. Participating suppliers can sell one or more of the Company’s payment obligations at their sole discretion. The Company has no economic interest in a supplier’s decision to sell one or more of its payment obligations. The Company’s rights and obligations with respect to such payment obligations, including amounts due and scheduled payment terms, are not impacted by suppliers’ decisions to sell amounts under these arrangements. The agreement has a limit of $60.0 million in payment obligations ($85.0 million during peak season from August to January). There is no requirement to provide assets pledged as security or other forms of guarantees under the agreement. The Company pays the third-party administrator based upon the original payment terms negotiated with participating suppliers. The payment of these obligations by the Company is included in cash used in operating activities in the Consolidated Statement of Cash Flows.
U.S. Treasury Bills	U.S. Treasury Bills During the third quarter of 2024, the Company invested $9.8 million of excess cash on hand into two U.S. Treasury Bills with original maturities of three and six months. U.S. Treasury Bills with an original maturity of 3 months or less are included within cash and cash equivalents on the Consolidated Balance Sheets and those greater than 3 months but less than one year are included within prepaid expenses and other current assets on the Consolidated Balance Sheets. The Company has classified these U.S. Treasury Bills as held-to-maturity as it intends to hold these securities until maturity. Held-to-maturity debt securities are recorded at amortized cost. Discounts from and premiums to par value on held-to-maturity debt securities are accreted/amortized into interest income over the life of the respective security using the effective interest method. The Company evaluates for other than temporary impairment on an ongoing basis. No impairment has been recognized for investments in debt securities for any period presented. As of September 30, 2024, the amortized cost and net carrying value of the securities recognized in cash and cash equivalents and prepaid expenses and other current assets were $5.0 million and $4.9 million, respectively.

Fair Value Disclosure (Tables)

9 Months Ended

Sep. 30, 2024

Fair Value Disclosures [Abstract]

Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis

The following table presents the Company’s assets and liabilities accounted for at fair value on a recurring basis:


Description	Balance Sheet Location	SEPTEMBER 30 2024		DECEMBER 31 2023		SEPTEMBER 30 2023
Assets:
Interest rate swap agreements
Current	Prepaid expenses and other current assets	$	798	$	511	$	929
Long-term	Other non-current assets	2,141		3,501		4,977
Foreign currency exchange contracts
Current	Prepaid expenses and other current assets	614		—		87
		$	3,553	$	4,012	$	5,993
Liabilities:



Foreign currency exchange contracts
Current	Other current liabilities	77		538		331
		$	77	$	538	$	331

Stockholders’ Equity (Tables)

9 Months Ended

Sep. 30, 2024

Equity [Abstract]

Schedule of Capital Stock

The following table sets forth the Company’s authorized capital stock information:


	SEPTEMBER 30 2024	DECEMBER 31 2023	SEPTEMBER 30 2023

Preferred stock, par value $0.01 per share
Preferred stock authorized	5,000	5,000	5,000
Preferred stock outstanding	—	—	—
Class A Common stock, par value $0.01 per share
Class A Common authorized	70,000	70,000	70,000
Class A Common issued (1)(2)	11,459	11,161	11,126
Treasury Stock (3)	1,349	877	766
Class B Common stock, par value $0.01 per share, convertible into Class A Common stock on a one-for-one basis
Class B Common authorized	30,000	30,000	30,000
Class B Common issued (1)	3,608	3,616	3,625

Schedule of Accumulated Other Comprehensive Loss

The following table summarizes changes in accumulated other comprehensive loss by component and related tax effects for periods shown:


	Foreign Currency		Deferred Gain (Loss) on Cash Flow Hedging		Pension Plan Adjustment		Total

Balance, January 1, 2024	$	(6,412)	$	2,424	$	(6,679)	$	(10,667)
Other comprehensive income (loss)	(1,097)		29		—		(1,068)
Reclassification adjustment to net income (loss)	—		647		94		741
Tax effects	—		(167)		(23)		(190)
Balance, March 31, 2024	(7,509)		2,933		(6,608)		(11,184)
Other comprehensive income (loss)	(1,868)		2,104		—		236
Reclassification adjustment to net income (loss)	—		(1,325)		83		(1,242)
Tax effects	—		(215)		(22)		(237)
Balance, June 30, 2024	(9,377)		3,497		(6,547)		(12,427)
Other comprehensive income (loss)	(516)		(944)		932		(528)
Reclassification adjustment to net income (loss)	—		(310)		7,649		7,339
Tax effects	—		276		(2,191)		(1,915)
Balance, September 30, 2024	$	(9,893)	$	2,519	$	(157)	$	(7,531)

Balance, January 1, 2023	$	(8,924)	$	4,158	$	(7,152)	$	(11,918)
Other comprehensive income (loss)	715		(1,881)		—		(1,166)
Reclassification adjustment to net income (loss)	—		252		87		339
Tax effects	(194)		379		(23)		162
Balance, March 31, 2023	(8,403)		2,908		(7,088)		(12,583)
Other comprehensive income (loss)	425		(59)		—		366
Reclassification adjustment to net income (loss)	—		465		83		548
Tax effects	186		(89)		(23)		74
Balance, June 30, 2023	(7,792)		3,225		(7,028)		(11,595)
Other comprehensive income (loss)	(661)		329		—		(332)
Reclassification adjustment to net income (loss)	—		648		95		743
Tax effects	—		(255)		(22)		(277)
Balance, September 30, 2023	$	(8,453)	$	3,947	$	(6,955)	$	(11,461)

Revenue (Tables)

9 Months Ended

Sep. 30, 2024

Revenue from Contract with Customer [Abstract]

Schedule of Disaggregation of Revenue

The following table sets forth Company’s revenue on a disaggregated basis for the three and nine months ended September 30:


	THREE MONTHS ENDED SEPTEMBER 30				NINE MONTHS ENDED SEPTEMBER 30
	2024		2023		2024		2023
Type of good or service:
Consumer products	$	141,862	$	138,849	$	394,397	$	374,842
Commercial products	12,041		13,159		39,914		40,234
Licensing	1,841		1,606		4,801		3,899
Leasing	923		—		2,072		—
Total revenues	$	156,667	$	153,614	$	441,184	$	418,975

Acquisitions (Tables)

9 Months Ended

Sep. 30, 2024

Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]

Schedule of Preliminary Assets Acquired and Liabilities Assumed

The following table presents the preliminary value of assets acquired and liabilities assumed and will be finalized pending completion of purchase accounting matters:


	Preliminary Fair Values as of February 2, 2024
Cash and cash equivalents	$	147


Current assets	1,452
Property, plant and equipment, net	6,634

Goodwill	847
Other intangible assets, net	1,111

Total assets acquired	10,191
Liabilities, current	2,016
Liabilities, non-current	616
Total liabilities acquired	2,632
Purchase Price	$	7,559

Basis of Presentation and Recently Issued Accounting Standards (Details) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024 USD ($) treasuryBill	Sep. 30, 2023 USD ($)	Sep. 30, 2024 USD ($)	Sep. 30, 2023 USD ($)	Aug. 31, 2024 USD ($)	Dec. 31, 2023 USD ($)
Basis of Presentation and Policies [Line Items]
Deferred loss within accumulated other comprehensive income	$ 100		$ 100
Surplus assets					$ 13,300
Reclassification related to pension termination activity into earnings, post-tax	5,658	$ 0	5,658	$ 0
Reclassification related to pension termination activity into earnings, before tax	7,600
Limit on payment obligations	60,000		60,000
Outstanding payment obligations, current	$ 70,100	$ 72,800	$ 70,100	$ 72,800		$ 55,000
Supplier Finance Program, Obligation, Current, Statement of Financial Position [Extensible Enumeration]	Accounts payable	Accounts payable	Accounts payable	Accounts payable		Accounts payable
Settlement of outstanding payment obligations	$ 60,800	$ 63,800	$ 60,800	$ 63,800		$ 48,900
Investments of excess cash on hand	$ 9,800
Number of U.S. treasury bills \| treasuryBill	2
Cash and cash equivalents
Basis of Presentation and Policies [Line Items]
Debt securities, held-to-maturity, amortized cost	$ 5,000		5,000
Prepaid expenses and other current assets
Basis of Presentation and Policies [Line Items]
Debt securities, held-to-maturity, amortized cost	4,900		4,900
Maximum
Basis of Presentation and Policies [Line Items]
Limit on payment obligations	85,000		85,000
Letter of Credit \| HBB Facility
Basis of Presentation and Policies [Line Items]
Line of credit facility, maximum borrowing capacity	$ 150,000		$ 150,000

Transfer of Financial Assets (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Transfers and Servicing [Abstract]
Accounts receivable derecognized	$ 33.5	$ 30.7	$ 104.1	$ 90.0	$ 128.7
Loss on sale of accounts receivable	$ 0.0	$ 0.0	$ 0.0	$ 0.0

Fair Value Disclosure (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023	Sep. 30, 2023
Letter of Credit \| HBB Facility
Liabilities:
Line of credit facility, maximum borrowing capacity	$ 150,000
Fair value measurements, recurring
Assets:
Assets at fair value	3,553	$ 4,012	$ 5,993
Liabilities:
Liabilities at fair value	77	538	331
Fair value measurements, recurring \| Prepaid expenses and other current assets
Assets:
Interest rate swap agreements	798	511	929
Foreign currency exchange contracts	614	0	87
Fair value measurements, recurring \| Other non-current assets
Assets:
Interest rate swap agreements	2,141	3,501	4,977
Fair value measurements, recurring \| Other current liabilities
Liabilities:
Foreign currency exchange contracts	$ 77	$ 538	$ 331

Stockholders’ Equity - Schedule of Capital Stock (Details) shares in Thousands		3 Months Ended		9 Months Ended
	Mar. 05, 2024 shares	Sep. 30, 2024 $ / shares shares	Sep. 30, 2023 $ / shares shares	Sep. 30, 2024 $ / shares shares	Sep. 30, 2023 $ / shares shares	Dec. 31, 2023 $ / shares shares
Class of Stock [Line Items]
Preferred stock, par value (in dollars per share) \| $ / shares		$ 0.01	$ 0.01	$ 0.01	$ 0.01	$ 0.01
Preferred stock authorized (in shares)		5,000	5,000	5,000	5,000	5,000
Preferred stock outstanding (in shares)		0	0	0	0	0
Class A Common stock
Class of Stock [Line Items]
Common stock, par value (in dollars per share) \| $ / shares		$ 0.01	$ 0.01	$ 0.01	$ 0.01	$ 0.01
Common stock authorized (in shares)		70,000	70,000	70,000	70,000	70,000
Common stock issued (in shares)		11,459	11,126	11,459	11,126	11,161
Treasury Stock (in shares)		1,349	766	1,349	766	877
Class A common shares issued (in shares)		14	28	290	244
Class A Common stock \| Incentive Plan
Class of Stock [Line Items]
Number of shares surrendered to satisfy tax withholding obligation	30
Class B Common stock
Class of Stock [Line Items]
Common stock, par value (in dollars per share) \| $ / shares		$ 0.01	$ 0.01	$ 0.01	$ 0.01	$ 0.01
Common stock, convertible conversion ratio		1	1	1	1	1
Common stock authorized (in shares)		30,000	30,000	30,000	30,000	30,000
Common stock issued (in shares)		3,608	3,625	3,608	3,625	3,616
Class B common converted to Class A common (in shares)		3	4	8	219

Stockholders’ Equity - Stock Repurchase Program (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023	Nov. 30, 2023
Class of Stock [Line Items]
Stock repurchased (in shares)	221,529	82,676	441,741	139,649	250,772
Aggregate purchase price	$ 5.3	$ 0.9	$ 9.3	$ 1.5	$ 3.1
Remaining authorized repurchase amount	$ 15.7		$ 15.7
Shares Outstanding Class A
Class of Stock [Line Items]
Stock repurchase program, number of shares authorized to be repurchased (in shares)						25,000,000

Stockholders’ Equity - Schedule of Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	$ 145,732	$ 145,407	$ 147,267	$ 118,366	$ 118,429	$ 124,534
Other comprehensive income (loss)	(528)	236	(1,068)	(332)	366	(1,166)
Reclassification adjustment to net income (loss)	7,339	(1,242)	741	743	548	339
Tax effects	(1,915)	(237)	(190)	(277)	74	162
Ending balance	149,951	145,732	145,407	127,820	118,366	118,429
Accumulated Other Comprehensive Income (Loss)
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	(12,427)	(11,184)	(10,667)	(11,595)	(12,583)	(11,918)
Ending balance	(7,531)	(12,427)	(11,184)	(11,461)	(11,595)	(12,583)
Foreign Currency
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	(9,377)	(7,509)	(6,412)	(7,792)	(8,403)	(8,924)
Other comprehensive income (loss)	(516)	(1,868)	(1,097)	(661)	425	715
Reclassification adjustment to net income (loss)	0	0	0	0	0	0
Tax effects	0	0	0	0	186	(194)
Ending balance	(9,893)	(9,377)	(7,509)	(8,453)	(7,792)	(8,403)
Deferred Gain (Loss) on Cash Flow Hedging
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	3,497	2,933	2,424	3,225	2,908	4,158
Other comprehensive income (loss)	(944)	2,104	29	329	(59)	(1,881)
Reclassification adjustment to net income (loss)	(310)	(1,325)	647	648	465	252
Tax effects	276	(215)	(167)	(255)	(89)	379
Ending balance	2,519	3,497	2,933	3,947	3,225	2,908
Pension Plan Adjustment
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	(6,547)	(6,608)	(6,679)	(7,028)	(7,088)	(7,152)
Other comprehensive income (loss)	932	0	0	0	0	0
Reclassification adjustment to net income (loss)	7,649	83	94	95	83	87
Tax effects	(2,191)	(22)	(23)	(22)	(23)	(23)
Ending balance	$ (157)	$ (6,547)	$ (6,608)	$ (6,955)	$ (7,028)	$ (7,088)

Revenue - Narrative (Details)	9 Months Ended
Revenue - Narrative (Details)	Sep. 30, 2024
Commercial products \| Geographic Concentration Risk \| Revenue from Contract with Customer Benchmark \| United States
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	67.00%
Commercial products \| Geographic Concentration Risk \| Revenue from Contract with Customer Benchmark \| Non-US
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	33.00%
Maximum \| Electric appliances
Disaggregation of Revenue [Line Items]
Warranty term	10 years
Maximum \| Other products
Disaggregation of Revenue [Line Items]
Warranty term	3 years
Maximum \| Consumer products
Disaggregation of Revenue [Line Items]
Revenue contract duration	1 year
Maximum \| Commercial products
Disaggregation of Revenue [Line Items]
Revenue contract duration	1 year
Minimum \| Other products
Disaggregation of Revenue [Line Items]
Warranty term	1 year

Revenue - Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Disaggregation of Revenue [Line Items]
Leasing	$ 923	$ 0	$ 2,072	$ 0
Total revenues	156,667	153,614	441,184	418,975
Consumer products
Disaggregation of Revenue [Line Items]
Revenue	141,862	138,849	394,397	374,842
Commercial products
Disaggregation of Revenue [Line Items]
Revenue	12,041	13,159	39,914	40,234
Licensing
Disaggregation of Revenue [Line Items]
Revenue	$ 1,841	$ 1,606	$ 4,801	$ 3,899

Contingencies (Details) $ in Millions	9 Months Ended
Contingencies (Details) $ in Millions	Sep. 30, 2024 USD ($) numberOfSite	Dec. 31, 2023 USD ($)	Sep. 30, 2023 USD ($)
Loss Contingencies [Line Items]
Accrual for environmental investigation and remediation activities	$ 3.5	$ 3.4	$ 3.4
Portion of loss contingency proceeds representing restricted cash	0.9
Asset associated with reimbursement of costs	$ 1.6
Loss contingency, number of sites associated with cost reimbursement \| numberOfSite	2
Minimum
Loss Contingencies [Line Items]
Estimate of additional expenses	$ 0.0
Maximum
Loss Contingencies [Line Items]
Estimate of additional expenses	$ 1.7

Income Taxes (Details)	3 Months Ended		9 Months Ended
Income Taxes (Details)	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Income Tax Disclosure [Abstract]
Effective tax rate	27.40%	21.60%	34.70%	19.70%

Acquisitions - Narrative (Details) - HealthBeacon € in Millions			3 Months Ended	9 Months Ended
	Feb. 02, 2024 EUR (€)	Feb. 02, 2024 USD ($)	Sep. 30, 2024 USD ($)	Sep. 30, 2024 USD ($)
Asset Acquisition [Line Items]
Business combination, consideration transferred	€ 6.9	$ 7,500,000
Revenues			$ 1,200,000	$ 2,600,000
Operating loss			1,100,000	3,700,000
Adjustments			0
Transaction costs			$ 200,000	$ 1,300,000

Acquisitions - Schedule of Preliminary Assets Acquired and Liabilities Assumed (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Feb. 02, 2024	Dec. 31, 2023	Sep. 30, 2023
Asset Acquisition [Line Items]
Goodwill	$ 7,099		$ 6,253	$ 6,253
HealthBeacon
Asset Acquisition [Line Items]
Cash and cash equivalents		$ 147
Current assets		1,452
Property, plant and equipment, net		6,634
Goodwill		847
Other intangible assets, net		1,111
Total assets acquired		10,191
Liabilities, current		2,016
Liabilities, non-current		616
Total liabilities acquired		2,632
Purchase Price		$ 7,559

Grafico Azioni Hamilton Beach Brands (NYSE:HBB)
Storico
Da Nov 2024 a Dic 2024

Clicca qui per i Grafici di Hamilton Beach Brands

Grafico Azioni Hamilton Beach Brands (NYSE:HBB)
Storico
Da Dic 2023 a Dic 2024

HBB Hamilton Beach Brands Holding Company

Notizie Hamilton Beach Brands Holding Company - HBB

La tua Cronologia

Più Attivi

Toplist

HBB Hamilton Beach Brands Holding Company

Notizie Hamilton Beach Brands Holding Company - HBB

La tua Cronologia